Permanent	O
occupancy	O
of	O
the	O
human	B-DNA
immunodeficiency	I-DNA
virus	I-DNA
type	I-DNA
1	I-DNA
enhancer	I-DNA
by	O
NF-kappa	B-protein
B	I-protein
is	O
needed	O
for	O
persistent	O
viral	O
replication	O
in	O
monocytes	B-cell_type
.	O

This	O
work	O
aimed	O
to	O
ascertain	O
the	O
role	O
of	O
kappaB-responsive	B-DNA
elements	I-DNA
of	O
the	O
human	B-DNA
immunodeficiency	I-DNA
virus	I-DNA
type	I-DNA
1	I-DNA
(	I-DNA
HIV-1	I-DNA
)	I-DNA
enhancer	I-DNA
not	O
only	O
in	O
early	O
initiation	O
but	O
also	O
in	O
long-term	O
maintenance	O
of	O
proviral	O
transcription	O
in	O
cells	O
of	O
the	O
monocytic	B-cell_type
lineage	I-cell_type
.	O

For	O
this	O
purpose	O
,	O
we	O
used	O
three	O
main	O
approaches	O
.	O

The	O
first	O
was	O
to	O
abruptly	O
terminate	O
tumor	O
necrosis	O
factor-induced	O
NF-kappaB	B-protein
binding	O
to	O
the	O
enhancer	O
sequences	O
in	O
U1	O
monocytic	O
cells	O
,	O
using	O
a	O
short	O
pulse	O
of	O
exogenous	B-protein
tumor	I-protein
necrosis	I-protein
factor	I-protein
.	O

This	O
resulted	O
in	O
concomitant	O
decrease	O
in	O
nuclear	O
NF-kappaB	B-protein
DNA-binding	O
activity	O
and	O
endogenous	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
transcriptional	O
activity	O
.	O

The	O
second	O
was	O
to	O
suppress	O
the	O
permanent	O
NF-kappaB	B-protein
translocation	O
induced	O
by	O
HIV-1	O
replication	O
itself	O
in	O
chronically	B-cell_line
infected	I-cell_line
U937	I-cell_line
cells	I-cell_line
,	O
using	O
a	O
specific	O
proteasome	O
inhibitor	O
(	O
Z-LLL-H	O
)	O
.	O

As	O
early	O
as	O
2	O
h	O
after	O
addition	O
of	O
the	O
inhibitor	O
to	O
the	O
culture	O
medium	O
,	O
there	O
was	O
an	O
inhibition	O
of	O
both	O
constitutive	O
activation	O
of	O
NF-kappaB	B-protein
and	O
HIV-1	O
genome	O
expression	O
.	O

The	O
third	O
approach	O
was	O
to	O
monitor	O
the	O
replication	O
competence	O
in	O
U937	B-cell_line
cells	I-cell_line
of	O
an	O
infectious	O
HIV-1	O
provirus	O
carrying	O
point	O
mutations	O
in	O
the	O
kappaB-responsive	B-DNA
elements	I-DNA
of	O
both	O
long	B-DNA
terminal	I-DNA
repeats	I-DNA
.	O

Compared	O
with	O
its	O
wild-type	O
counterpart	O
,	O
this	O
mutated	O
provirus	O
showed	O
a	O
profoundly	O
decreased	O
,	O
Z-LLL-H-insensitive	O
transcriptional	O
and	O
replicative	O
activity	O
in	O
U937	B-cell_line
monocytes	I-cell_line
.	O

Together	O
,	O
our	O
results	O
indicate	O
that	O
occupancy	O
of	O
the	O
viral	B-DNA
enhancer	I-DNA
by	O
NF-kappaB	B-protein
(	I-protein
p50/p65	I-protein
)	I-protein
heterodimers	I-protein
is	O
required	O
for	O
ongoing	O
transcription	O
of	O
integrated	O
HIV	O
provirus	O
in	O
monocytes	B-cell_type
,	O
even	O
in	O
cells	O
chronically	O
infected	O
and	O
permanently	O
producing	O
functional	O
HIV	B-protein
Tat	I-protein
protein	I-protein
.	O

Thus	O
,	O
the	O
ability	O
of	O
HIV-1	O
replication	O
to	O
activate	O
NF-kappaB	B-protein
is	O
crucial	O
to	O
the	O
intense	O
self-perpetuated	O
viral	O
transcription	O
observed	O
in	O
cells	O
of	O
the	O
monocytic	B-cell_type
lineage	I-cell_type
.	O

JournaL	NULL
or	NULL
VirRoLoGy	NULL
,	NULL
May	NULL
1996	NULL
,	NULL
p.	NULL
2930-2938	NULL
0022-538	NULL
Copyright	NULL
©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

70	NULL
,	NULL
No	NULL
.	NULL

5	NULL
Permanent	NULL
Occupancy	NULL
of	NULL
the	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Type	NULL
1	NULL
Enhancer	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
Is	NULL
Needed	NULL
for	NULL
Persistent	NULL
Viral	NULL
Replication	NULL
in	NULL
Monocytes	NULL
J.-M.	NULL
JACQUE	NULL
,	NULL
'	NULL
B.	NULL
FERNANDEZ	NULL
,	NULL
!	NULL

F.	NULL
ARENZANA-SEISDEDOS	NULL
,	NULL
'	NULL
D.	NULL
THOMAS	NULL
,	NULL
!	NULL

F.	NULL
BALEUX	NULL
,	NULL
``	NULL
J.-L.	NULL
VIRELIZIER	NULL
,	NULL
'	NULL
anp	NULL
F	NULL
.	NULL

BACHELERIE	NULL
!	NULL

*	NULL
Unité	NULL
d	NULL
'	NULL
Immunologie	NULL
and	NULL
Unité	NULL
de	NULL
Chimie	NULL
Organique	NULL
,	NULL
``	NULL
Institut	NULL
Pasteur	NULL
,	NULL
75724	NULL
Paris	NULL
Cedex	NULL
15	NULL
,	NULL
France	NULL
Received	NULL
20	NULL
November	NULL
1995/Accepted	NULL
23	NULL
January	NULL
1996	NULL
This	NULL
work	NULL
aimed	NULL
to	NULL
ascertain	NULL
the	NULL
role	NULL
of	NULL
«	NULL
B-responsive	NULL
elements	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
enhancer	NULL
not	NULL
only	NULL
in	NULL
early	NULL
initiation	NULL
but	NULL
also	NULL
in	NULL
long-term	NULL
maintenance	NULL
of	NULL
proviral	NULL
transcription	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocytic	NULL
lineage	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
we	NULL
used	NULL
three	NULL
main	NULL
approaches	NULL
.	NULL

The	NULL
first	NULL
was	NULL
to	NULL
abruptly	NULL
terminate	NULL
tumor	NULL
necrosis	NULL
factor-induced	NULL
NF-KB	NULL
binding	NULL
to	NULL
the	NULL
enhancer	NULL
sequences	NULL
in	NULL
Ul	NULL
monocytic	NULL
cells	NULL
,	NULL
using	NULL
a	NULL
short	NULL
pulse	NULL
of	NULL
exogenous	NULL
tumor	NULL
necrosis	NULL
factor	NULL
,	NULL
This	NULL
resulted	NULL
in	NULL
concomitant	NULL
decrease	NULL
in	NULL
nuclear	NULL
DNA-binding	NULL
activity	NULL
and	NULL
endogenous	NULL
long	NULL
terminal	NULL
repeat	NULL
transcriptional	NULL
activity	NULL
.	NULL

The	NULL
second	NULL
was	NULL
to	NULL
suppress	NULL
the	NULL
permanent	NULL
NF-KB	NULL
translocation	NULL
induced	NULL
by	NULL
HIV-1	NULL
replication	NULL
itself	NULL
in	NULL
chronically	NULL
infected	NULL
U937	NULL
cells	NULL
,	NULL
using	NULL
a	NULL
specific	NULL
proteasome	NULL
inhibitor	NULL
(	NULL
Z-LLL-H	NULL
)	NULL
.	NULL

As	NULL
early	NULL
as	NULL
2	NULL
h	NULL
after	NULL
addition	NULL
of	NULL
the	NULL
inhibitor	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
,	NULL
there	NULL
was	NULL
an	NULL
inhibition	NULL
of	NULL
both	NULL
constitutive	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
HIV-1	NULL
genome	NULL
expression	NULL
.	NULL

The	NULL
third	NULL
approach	NULL
was	NULL
to	NULL
monitor	NULL
the	NULL
replication	NULL
competence	NULL
in	NULL
U937	NULL
cells	NULL
of	NULL
an	NULL
infectious	NULL
HIV-1	NULL
provirus	NULL
carrying	NULL
point	NULL
mutations	NULL
in	NULL
the	NULL
«	NULL
B-responsive	NULL
elements	NULL
of	NULL
both	NULL
long	NULL
terminal	NULL
repeats	NULL
.	NULL

Compared	NULL
with	NULL
its	NULL
wild-type	NULL
counterpart	NULL
,	NULL
this	NULL
mutated	NULL
provirus	NULL
showed	NULL
a	NULL
profoundly	NULL
decreased	NULL
,	NULL
Z-LLL-H-insensitive	NULL
transcriptional	NULL
and	NULL
replicative	NULL
activity	NULL
in	NULL
U937	NULL
monocytes	NULL
.	NULL

Together	NULL
,	NULL
our	NULL
results	NULL
indicate	NULL
that	NULL
occupancy	NULL
of	NULL
the	NULL
viral	NULL
enhancer	NULL
by	NULL
NF-B	NULL
(	NULL
p50/p65	NULL
)	NULL
heterodimers	NULL
is	NULL
required	NULL
for	NULL
ongoing	NULL
transcription	NULL
of	NULL
integrated	NULL
HIV	NULL
provirus	NULL
in	NULL
monocytes	NULL
,	NULL
even	NULL
in	NULL
cells	NULL
chronically	NULL
infected	NULL
and	NULL
permanently	NULL
producing	NULL
functional	NULL
HIV	NULL
Tat	NULL
protein	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
HIV-1	NULL
replication	NULL
to	NULL
activate	NULL
NF-KB	NULL
is	NULL
crucial	NULL
to	NULL
the	NULL
intense	NULL
self-perpetuated	NULL
viral	NULL
transcription	NULL
observed	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocytic	NULL
lineage	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
genome	NULL
depends	NULL
on	NULL
the	NULL
intracellular	NULL
environment	NULL
into	NULL
which	NULL
the	NULL
virus	NULL
integrates	NULL
and	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
complex	NULL
interplay	NULL
between	NULL
viral	NULL
regulatory	NULL
proteins	NULL
and	NULL
cellular	NULL
transcription	NULL
factors	NULL
interacting	NULL
with	NULL
the	NULL
viral	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
region	NULL
.	NULL

In	NULL
1987	NULL
,	NULL
a	NULL
direct	NULL
correlation	NULL
was	NULL
established	NULL
between	NULL
the	NULL
up-regulation	NULL
of	NULL
LTR	NULL
transcriptional	NULL
activity	NULL
during	NULL
T-cell	NULL
activation	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
NF-kB	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
two	NULL
repeated	NULL
motifs	NULL
in	NULL
the	NULL
core	NULL
enhancer	NULL
element	NULL
of	NULL
the	NULL
LTR	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Since	NULL
this	NULL
early	NULL
study	NULL
,	NULL
the	NULL
notion	NULL
of	NULL
the	NULL
critical	NULL
dependence	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
function	NULL
on	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
has	NULL
received	NULL
considerable	NULL
experimental	NULL
support	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
25	NULL
)	NULL
.	NULL

The	NULL
human	NULL
family	NULL
of	NULL
ReI/NF-	NULL
«	NULL
B	NULL
proteins	NULL
is	NULL
composed	NULL
of	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
RelB	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
25	NULL
)	NULL
.	NULL

While	NULL
almost	NULL
all	NULL
combinations	NULL
of	NULL
homo-	NULL
and	NULL
heterodimers	NULL
may	NULL
exist	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
which	NULL
is	NULL
rapidly	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
extra-cellular	NULL
signals	NULL
,	NULL
is	NULL
typically	NULL
composed	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
.	NULL

While	NULL
p50	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
possess	NULL
a	NULL
domain	NULL
for	NULL
transcriptional	NULL
activation	NULL
,	NULL
the	NULL
p65	NULL
subunit	NULL
does	NULL
,	NULL
which	NULL
accounts	NULL
for	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
NF-kB	NULL
heterodimer	NULL
(	NULL
20	NULL
,	NULL
58	NULL
)	NULL
.	NULL

The	NULL
p50	NULL
subunit	NULL
is	NULL
derived	NULL
from	NULL
a	NULL
p105	NULL
precursor	NULL
by	NULL
ubiquitin-mediated	NULL
proteolysis	NULL
of	NULL
the	NULL
C-terminal	NULL
region	NULL
of	NULL
p105	NULL
(	NULL
46	NULL
)	NULL
.	NULL

When	NULL
expressed	NULL
from	NULL
an	NULL
alternatively	NULL
spliced	NULL
p105	NULL
mRNA	NULL
lacking	NULL
the	NULL
p50	NULL
coding	NULL
sequences	NULL
,	NULL
this	NULL
C-terminal	NULL
region	NULL
(	NULL
IxBy	NULL
)	NULL
preferentially	NULL
inhibits	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
p50	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Unité	NULL
d'Immunologie	NULL
Vi-rale	NULL
,	NULL
Institut	NULL
Pasteur	NULL
,	NULL
28	NULL
rue	NULL
du	NULL
Dr	NULL
Roux	NULL
,	NULL
75724	NULL
Paris	NULL
Cedex	NULL
15	NULL
,	NULL
France	NULL
.	NULL

Phone	NULL
:	NULL
33	NULL
(	NULL
1	NULL
)	NULL
45	NULL
68	NULL
82	NULL
62	NULL
.	NULL

Fax	NULL
:	NULL
33	NULL
(	NULL
1	NULL
)	NULL
45	NULL
68	NULL
89	NULL
41	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
foachele	NULL
@	NULL
pasteur.fr	NULL
.	NULL

2930	NULL
homodimers	NULL
(	NULL
33	NULL
,	NULL
35	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
NF-KB	NULL
is	NULL
controlled	NULL
by	NULL
the	NULL
inhibitor	NULL
protein	NULL
IxBa	NULL
(	NULL
or	NULL
MAD3	NULL
)	NULL
(	NULL
6	NULL
,	NULL
29	NULL
)	NULL
,	NULL
which	NULL
,	NULL
in	NULL
common	NULL
with	NULL
IkBy	NULL
,	NULL
Bel-3	NULL
,	NULL
and	NULL
IBB	NULL
(	NULL
62	NULL
,	NULL
66	NULL
)	NULL
,	NULL
contains	NULL
multiple	NULL
ankyrin	NULL
repeats	NULL
.	NULL

Exposure	NULL
of	NULL
cells	NULL
to	NULL
signals	NULL
which	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
results	NULL
in	NULL
the	NULL
rapid	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
(	NULL
7	NULL
,	NULL
10	NULL
,	NULL
30	NULL
,	NULL
40	NULL
,	NULL
60	NULL
)	NULL
.	NULL

Degradation	NULL
of	NULL
IxBa	NULL
is	NULL
rapidly	NULL
followed	NULL
by	NULL
induction	NULL
of	NULL
IkxBa	NULL
«	NULL
mRNA	NULL
through	NULL
a	NULL
mechanism	NULL
regulated	NULL
by	NULL
the	NULL
interaction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
DNA	NULL
recognition	NULL
sites	NULL
located	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
IxBa	NULL
gene	NULL
(	NULL
14	NULL
,	NULL
34	NULL
,	NULL
60	NULL
)	NULL
.	NULL

Newly	NULL
synthesized	NULL
IxBa	NULL
protein	NULL
appears	NULL
transiently	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
negatively	NULL
regulates	NULL
NF-	NULL
«	NULL
B-dependent	NULL
transcription	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
multicatalytic	NULL
268	NULL
proteasome	NULL
complex	NULL
,	NULL
shown	NULL
to	NULL
catalyze	NULL
the	NULL
generation	NULL
of	NULL
antigenic	NULL
peptides	NULL
for	NULL
presentation	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I	NULL
antigen	NULL
molecules	NULL
(	NULL
54	NULL
)	NULL
,	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
ATP-dependent	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
use	NULL
of	NULL
peptide	NULL
aldehydes	NULL
which	NULL
specifically	NULL
inhibit	NULL
the	NULL
chymotrypsin	NULL
activity	NULL
of	NULL
the	NULL
proteasome	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
has	NULL
been	NULL
proven	NULL
that	NULL
covalent	NULL
attachment	NULL
of	NULL
polyubiquitin	NULL
chains	NULL
to	NULL
IxBa	NULL
«	NULL
is	NULL
required	NULL
for	NULL
protea-some-activated	NULL
degradation	NULL
of	NULL
the	NULL
protein	NULL
both	NULL
in	NULL
vitro	NULL
(	NULL
13	NULL
)	NULL
and	NULL
in	NULL
vivo	NULL
following	NULL
cell	NULL
activation	NULL
(	NULL
55	NULL
)	NULL
.	NULL

Interesting	NULL
evidence	NULL
has	NULL
also	NULL
emerged	NULL
that	NULL
the	NULL
enhancer-independent	NULL
inducibility	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
may	NULL
involve	NULL
the	NULL
participation	NULL
of	NULL
other	NULL
cellular	NULL
factors	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
21	NULL
)	NULL
and	NULL
the	NULL
p53	NULL
protein	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Transcriptional	NULL
synergism	NULL
between	NULL
distinct	NULL
,	NULL
virus-inducible	NULL
enhancer	NULL
elements	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
human	NULL
beta	NULL
interferon	NULL
gene	NULL
promoter	NULL
has	NULL
been	NULL
reported	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
context	NULL
,	NULL
NF-kB	NULL
may	NULL
act	NULL
in	NULL
synergy	NULL
with	NULL
the	NULL
transcription	NULL
factor	NULL
Sp1	NULL
,	NULL
either	NULL
through	NULL
the	NULL
establishment	NULL
of	NULL
a	NULL
direct	NULL
interaction	NULL
(	NULL
48	NULL
,	NULL
49	NULL
)	NULL
or	NULL
after	NULL
Sp1	NULL
voL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
phosphorylation	NULL
(	NULL
64	NULL
)	NULL
.	NULL

A	NULL
complex	NULL
picture	NULL
of	NULL
HIV-1	NULL
LTR	NULL
regulation	NULL
has	NULL
emerged	NULL
from	NULL
these	NULL
accumulated	NULL
data	NULL
.	NULL

However	NULL
,	NULL
analyses	NULL
performed	NULL
in	NULL
normal	NULL
T	NULL
lymphocytes	NULL
and	NULL
primary	NULL
macrophages	NULL
emphasized	NULL
the	NULL
essential	NULL
role	NULL
of	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
for	NULL
the	NULL
initiation	NULL
of	NULL
LTR	NULL
transcriptional	NULL
activity	NULL
and	NULL
HIV-1	NULL
Tat-dependent	NULL
LTR	NULL
transactivation	NULL
(	NULL
2	NULL
,	NULL
43	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
an	NULL
absolute	NULL
requirement	NULL
of	NULL
enhancer	NULL
sequences	NULL
for	NULL
the	NULL
establishment	NULL
of	NULL
HIV-1	NULL
infection	NULL
in	NULL
peripheral	NULL
blood	NULL
CD4	NULL
lymphocytes	NULL
(	NULL
2	NULL
)	NULL
.	NULL

This	NULL
study	NULL
led	NULL
to	NULL
the	NULL
notion	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
p65/p50	NULL
heterodimer	NULL
binding	NULL
to	NULL
the	NULL
enhancer	NULL
domain	NULL
plays	NULL
a	NULL
driving	NULL
role	NULL
in	NULL
HIV-1	NULL
LTR	NULL
transcriptional	NULL
activity	NULL
by	NULL
both	NULL
initiating	NULL
this	NULL
activity	NULL
and	NULL
cooperating	NULL
with	NULL
the	NULL
Tat	NULL
protein	NULL
,	NULL
thus	NULL
constituting	NULL
a	NULL
prerequisite	NULL
for	NULL
the	NULL
establishment	NULL
of	NULL
HIV-1	NULL
replication	NULL
in	NULL
normal	NULL
T	NULL
lymphocytes	NULL
.	NULL

In	NULL
monocytes/macrophages	NULL
,	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
and	NULL
HIV-1	NULL
LTR	NULL
reporter	NULL
gene	NULL
expression	NULL
are	NULL
also	NULL
coordinately	NULL
inducible	NULL
(	NULL
5	NULL
,	NULL
24	NULL
,	NULL
43	NULL
,	NULL
47	NULL
,	NULL
56	NULL
)	NULL
.	NULL

In	NULL
this	NULL
cell	NULL
type	NULL
,	NULL
the	NULL
contribution	NULL
of	NULL
enhancer	NULL
occupancy	NULL
by	NULL
NF-kB	NULL
to	NULL
HIV-1	NULL
replication	NULL
has	NULL
been	NULL
analyzed	NULL
primarily	NULL
in	NULL
myelomonocytic	NULL
U1	NULL
cells	NULL
.	NULL

This	NULL
cell	NULL
line	NULL
,	NULL
originally	NULL
cloned	NULL
from	NULL
the	NULL
chronically	NULL
HIV-1	NULL
;	NULL
,	NULL
promonocytic	NULL
cell	NULL
line	NULL
U937	NULL
,	NULL
was	NULL
found	NULL
to	NULL
have	NULL
very	NULL
low	NULL
basal	NULL
expression	NULL
of	NULL
two	NULL
integrated	NULL
HIV	NULL
genome	NULL
copies	NULL
but	NULL
to	NULL
retain	NULL
the	NULL
ability	NULL
to	NULL
produce	NULL
large	NULL
quantities	NULL
of	NULL
infectious	NULL
virus	NULL
when	NULL
stimulated	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
inducing	NULL
effect	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
on	NULL
endogenous	NULL
HIV-1	NULL
replication	NULL
in	NULL
U1	NULL
cells	NULL
has	NULL
been	NULL
correlated	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
binding	NULL
to	NULL
the	NULL
viral	NULL
enhancer	NULL
(	NULL
18	NULL
,	NULL
24	NULL
,	NULL
51	NULL
)	NULL
and	NULL
the	NULL
stimulation	NULL
of	NULL
newly	NULL
transcribed	NULL
HIV-1	NULL
RNAs	NULL
(	NULL
50	NULL
,	NULL
51	NULL
)	NULL
.	NULL

In	NULL
monocytes/macrophages	NULL
and	NULL
T	NULL
lym-phocytes	NULL
,	NULL
the	NULL
two	NULL
main	NULL
cellular	NULL
targets	NULL
of	NULL
HIV	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
of	NULL
all	NULL
of	NULL
the	NULL
multiple	NULL
cellular	NULL
factors	NULL
which	NULL
interact	NULL
with	NULL
the	NULL
HIV-1	NULL
LTR	NULL
and	NULL
modulate	NULL
its	NULL
function	NULL
,	NULL
the	NULL
Rel/kB	NULL
family	NULL
is	NULL
the	NULL
principal	NULL
inducer	NULL
of	NULL
HIV-1	NULL
transcription	NULL
.	NULL

However	NULL
,	NULL
a	NULL
remarkable	NULL
feature	NULL
of	NULL
the	NULL
HIV-monocyte/macrophage	NULL
relationship	NULL
is	NULL
that	NULL
HIV-1	NULL
replication	NULL
itself	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
in	NULL
this	NULL
cell	NULL
lineage	NULL
(	NULL
5	NULL
,	NULL
56	NULL
,	NULL
57	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
p105	NULL
precursor	NULL
replenishes	NULL
the	NULL
p50	NULL
pool	NULL
and	NULL
allows	NULL
the	NULL
observed	NULL
permanent	NULL
activation	NULL
of	NULL
NF-KB	NULL
to	NULL
be	NULL
sustained	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Increased	NULL
IxBa	NULL
turnover	NULL
appears	NULL
to	NULL
account	NULL
for	NULL
the	NULL
constitutive	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
in	NULL
HIV-1-infected	NULL
monocytes	NULL
(	NULL
38	NULL
)	NULL
.	NULL

However	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
viral	NULL
transactivator	NULL
Tat	NULL
in	NULL
HIV-l-infected	NULL
U937	NULL
cells	NULL
also	NULL
participates	NULL
in	NULL
maintaining	NULL
this	NULL
high-level	NULL
,	NULL
permanent	NULL
HIV-1	NULL
genome	NULL
transcription	NULL
,	NULL
since	NULL
deletion	NULL
of	NULL
the	NULL
Tat-responsive	NULL
element	NULL
sequence	NULL
suppressed	NULL
most	NULL
,	NULL
but	NULL
not	NULL
all	NULL
,	NULL
transcriptional	NULL
activity	NULL
of	NULL
an	NULL
HIV-1	NULL
LTR	NULL
luciferase	NULL
expression	NULL
vector	NULL
transiently	NULL
transfected	NULL
into	NULL
chronically	NULL
infected	NULL
U937	NULL
cells	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
role	NULL
of	NULL
HIV	NULL
enhancer	NULL
occupancy	NULL
in	NULL
permanently	NULL
increased	NULL
HIV-1	NULL
LTR	NULL
transcriptional	NULL
activity	NULL
is	NULL
still	NULL
unclear	NULL
.	NULL

Hence	NULL
,	NULL
many	NULL
questions	NULL
concerning	NULL
the	NULL
importance	NULL
of	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
in	NULL
HIV-1	NULL
replication	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
myelomonocytic	NULL
lineage	NULL
remain	NULL
to	NULL
be	NULL
answered	NULL
.	NULL

First	NULL
,	NULL
is	NULL
NF-	NULL
«	NULL
kB	NULL
LTR-dependent	NULL
transcription	NULL
absolutely	NULL
required	NULL
for	NULL
the	NULL
establishment	NULL
of	NULL
HIV-1	NULL
replication	NULL
?	NULL

Second	NULL
,	NULL
is	NULL
HIV	NULL
Tat	NULL
ex-pression	NULL
,	NULL
induced	NULL
as	NULL
soon	NULL
as	NULL
LTR	NULL
function	NULL
is	NULL
ongoing	NULL
,	NULL
sufficient	NULL
to	NULL
perpetuate	NULL
proviral	NULL
transcription	NULL
in	NULL
an	NULL
enhancer-inde-pendent	NULL
manner	NULL
?	NULL

Third	NULL
,	NULL
the	NULL
kB	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
LTR	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
absolutely	NULL
essential	NULL
for	NULL
efficient	NULL
viral	NULL
replication	NULL
in	NULL
primary	NULL
macaque	NULL
macrophages	NULL
(	NULL
8	NULL
)	NULL
.	NULL

In	NULL
light	NULL
of	NULL
the	NULL
close	NULL
relationship	NULL
between	NULL
HIV	NULL
and	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
and	NULL
the	NULL
high	NULL
degree	NULL
of	NULL
conservation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
,	NULL
can	NULL
these	NULL
results	NULL
be	NULL
extrapolated	NULL
to	NULL
HIV-1	NULL
infection	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
?	NULL

Such	NULL
questions	NULL
are	NULL
particularly	NULL
relevant	NULL
with	NULL
respect	NULL
to	NULL
mac-rophages	NULL
,	NULL
in	NULL
which	NULL
HIV-1	NULL
transcription	NULL
and	NULL
replication	NULL
occur	NULL
in	NULL
a	NULL
persistent	NULL
manner	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
viral	NULL
cytopathogenic	NULL
PERSISTENT	NULL
REPLICATION	NULL
OF	NULL
HIV-1	NULL
IN	NULL
MONOCYTES	NULL
REQUIRES	NULL
NF-	NULL
«	NULL
B	NULL
2931	NULL
effects	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
22	NULL
,	NULL
32	NULL
,	NULL
and	NULL
41	NULL
)	NULL
.	NULL

They	NULL
are	NULL
critical	NULL
questions	NULL
,	NULL
because	NULL
monocytes/macrophages	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
the	NULL
main	NULL
cellular	NULL
sites	NULL
of	NULL
the	NULL
very	NULL
intense	NULL
viral	NULL
replication	NULL
observed	NULL
in	NULL
infected	NULL
patients	NULL
(	NULL
31	NULL
,	NULL
65	NULL
)	NULL
.	NULL

Using	NULL
the	NULL
U937	NULL
monocytic	NULL
cell	NULL
model	NULL
,	NULL
we	NULL
have	NULL
now	NULL
addressed	NULL
these	NULL
questions	NULL
by	NULL
suppressing	NULL
either	NULL
the	NULL
NF-	NULL
«	NULL
B-binding	NULL
elements	NULL
by	NULL
specific	NULL
mutation	NULL
or	NULL
the	NULL
permanent	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
induced	NULL
by	NULL
HIV-1	NULL
replication	NULL
.	NULL

We	NULL
monitored	NULL
the	NULL
consequences	NULL
of	NULL
such	NULL
manipulations	NULL
on	NULL
the	NULL
transcription	NULL
of	NULL
chronic	NULL
HIV-1	NULL
genome	NULL
expression	NULL
.	NULL

In	NULL
latently	NULL
infected	NULL
U1	NULL
cells	NULL
,	NULL
we	NULL
have	NULL
used	NULL
a	NULL
recently	NULL
described	NULL
(	NULL
3	NULL
)	NULL
method	NULL
allowing	NULL
a	NULL
controlled	NULL
,	NULL
transient	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
to	NULL
show	NULL
that	NULL
early	NULL
disappearance	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B-binding	NULL
activity	NULL
results	NULL
in	NULL
an	NULL
abortive	NULL
induction	NULL
of	NULL
HIV	NULL
provirus	NULL
transcription	NULL
after	NULL
a	NULL
pulse	NULL
of	NULL
TNF	NULL
.	NULL

Our	NULL
results	NULL
provide	NULL
support	NULL
for	NULL
the	NULL
conclusion	NULL
that	NULL
both	NULL
initiation	NULL
and	NULL
perpetuation	NULL
of	NULL
integrated	NULL
HIV	NULL
provirus	NULL
transcription	NULL
are	NULL
strictly	NULL
dependent	NULL
on	NULL
the	NULL
actual	NULL
occupancy	NULL
of	NULL
the	NULL
enhancer	NULL
sequence	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
cultures	NULL
and	NULL
infections	NULL
.	NULL

The	NULL
monocytic	NULL
cell	NULL
line	NULL
U937	NULL
,	NULL
latently	NULL
HIV-infected	NULL
U1	NULL
cells	NULL
(	NULL
19	NULL
)	NULL
(	NULL
obtained	NULL
from	NULL
the	NULL
NIH	NULL
AIDS	NULL
Research	NULL
and	NULL
Reference	NULL
Reagent	NULL
Program	NULL
)	NULL
,	NULL
and	NULL
the	NULL
lymphoblastoid	NULL
T-cell	NULL
line	NULL
CEM	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
glutamine	NULL
.	NULL

They	NULL
were	NULL
passaged	NULL
twice	NULL
a	NULL
week	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2.5	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
.	NULL

Infection	NULL
of	NULL
U937	NULL
cells	NULL
with	NULL
mycoplasma-negative	NULL
HIV-1	NULL
;	NULL
a	NULL
,	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
production	NULL
of	NULL
infectious	NULL
supernatants	NULL
from	NULL
either	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
or	NULL
«	NULL
B-mutated	NULL
(	NULL
xB-Mut	NULL
)	NULL
HIV	NULL
(	NULL
see	NULL
below	NULL
)	NULL
was	NULL
performed	NULL
in	NULL
CEM	NULL
,	NULL
U937	NULL
,	NULL
or	NULL
Cos-7	NULL
cells	NULL
.	NULL

Cos-7	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
glutamine	NULL
and	NULL
passaged	NULL
every	NULL
3	NULL
days	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
each	NULL
complementary	NULL
Bg/l-Neol-di-gested	NULL
proviral	NULL
construct	NULL
was	NULL
cotransfected	NULL
for	NULL
12	NULL
to	NULL
16	NULL
h	NULL
into	NULL
subconfluent	NULL
Cos-7	NULL
cells	NULL
seeded	NULL
1	NULL
day	NULL
before	NULL
transfection	NULL
at	NULL
4	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
75-cm*	NULL
flask	NULL
,	NULL
using	NULL
Lipofectamine	NULL
reagent	NULL
(	NULL
GibcoBRL	NULL
)	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
trypsinized	NULL
and	NULL
cultured	NULL
for	NULL
an	NULL
additional	NULL
48	NULL
h	NULL
before	NULL
harvesting	NULL
of	NULL
the	NULL
viral	NULL
supernatants	NULL
.	NULL

U937	NULL
and	NULL
CEM	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
RPMI	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
electroporated	NULL
at	NULL
250	NULL
V	NULL
and	NULL
960	NULL
wF	NULL
with	NULL
15	NULL
pg	NULL
of	NULL
DNA	NULL
per	NULL
10	NULL
``	NULL
cells	NULL
.	NULL

Cell-free	NULL
supernatants	NULL
were	NULL
assayed	NULL
for	NULL
the	NULL
HIV-1	NULL
p24	NULL
``	NULL
protein	NULL
by	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
Dupont	NULL
)	NULL
,	NULL
and	NULL
all	NULL
infections	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
p24®*	NULL
levels	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
to	NULL
15	NULL
x	NULL
10°	NULL
cells	NULL
infected	NULL
with	NULL
a	NULL
total	NULL
20	NULL
to	NULL
150	NULL
ng	NULL
of	NULL
p24	NULL
``	NULL
antigen	NULL
)	NULL
.	NULL

The	NULL
threshold	NULL
of	NULL
p24°	NULL
``	NULL
*	NULL
production	NULL
detectability	NULL
was	NULL
2.5	NULL
pg/ml	NULL
.	NULL

Proviral	NULL
constructs	NULL
.	NULL

The	NULL
HIV-1	NULL
wt	NULL
and	NULL
«	NULL
B-Mut	NULL
constructs	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Plasmid	NULL
puc§'HIV-arm	NULL
contains	NULL
a	NULL
BermHI-SphI	NULL
fragment	NULL
derived	NULL
from	NULL
the	NULL
molecular	NULL
clone	NULL
HIV-1SF2	NULL
linked	NULL
to	NULL
an	NULL
SpHI-Neo	NULL
!	NULL

fragment	NULL
originating	NULL
from	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
IB	NULL
pBH10	NULL
clone	NULL
.	NULL

puc3'HIV-arm	NULL
contains	NULL
the	NULL
NeoI-Narl	NULL
sequence	NULL
of	NULL
HIV-1SF2	NULL
.	NULL

The	NULL
wt	NULL
and	NULL
its	NULL
«	NULL
B-Mut	NULL
versions	NULL
differ	NULL
only	NULL
in	NULL
a	NULL
5-bp	NULL
substitution	NULL
(	NULL
AAGGG	NULL
and	NULL
TTTAA	NULL
,	NULL
respectively	NULL
)	NULL
in	NULL
the	NULL
enhancer	NULL
regions	NULL
of	NULL
the	NULL
5°	NULL
and	NULL
3	NULL
'	NULL
LTRs	NULL
.	NULL

These	NULL
noninfectious	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
plasmids	NULL
produce	NULL
infectious	NULL
virus	NULL
upon	NULL
Bg/I-Neol	NULL
digestion	NULL
and	NULL
cotransfection	NULL
.	NULL

Preparation	NULL
of	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
extracts	NULL
.	NULL

U1	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
5	NULL
ng	NULL
of	NULL
TNF	NULL
(	NULL
provided	NULL
by	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
AIDS	NULL
Research	NULL
and	NULL
Reference	NULL
Reagent	NULL
Program	NULL
)	NULL
per	NULL
ml	NULL
and	NULL
cultivated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

After	NULL
this	NULL
pulse-chase	NULL
,	NULL
experiments	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
50	NULL
ml	NULL
of	NULL
prewarmed	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
.	NULL

Half	NULL
of	NULL
the	NULL
culture	NULL
was	NULL
resuspended	NULL
in	NULL
prewarmed	NULL
culture	NULL
medium	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TNF	NULL
(	NULL
chase	NULL
)	NULL
,	NULL
and	NULL
the	NULL
other	NULL
half	NULL
was	NULL
resuspended	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
5	NULL
ng	NULL
of	NULL
TNF	NULL
per	NULL
ml	NULL
for	NULL
an	NULL
additional	NULL
6	NULL
h.	NULL
Unless	NULL
indicated	NULL
otherwise	NULL
,	NULL
in	NULL
experiments	NULL
using	NULL
the	NULL
peptide	NULL
aldehyde	NULL
Z-LLL-H	NULL
(	NULL
46	NULL
)	NULL
(	NULL
provided	NULL
by	NULL
F.	NULL
Baleux	NULL
,	NULL
Unité	NULL
de	NULL
Chimie	NULL
Or-ganique	NULL
,	NULL
Pasteur	NULL
Institute	NULL
)	NULL
,	NULL
uninfected	NULL
U937	NULL
cells	NULL
were	NULL
pretreated	NULL
for	NULL
110	NULL
min	NULL
with	NULL
this	NULL
reagent	NULL
(	NULL
at	NULL
concentrations	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
)	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
TNF	NULL
to	NULL
culture	NULL
media	NULL
for	NULL
an	NULL
additional	NULL
10	NULL
min	NULL
.	NULL

HIV-1-infected	NULL
U937	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
inhibitor	NULL
for	NULL
the	NULL
same	NULL
total	NULL
time	NULL
(	NULL
120	NULL
min	NULL
)	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
washed	NULL
in	NULL
cold	NULL
PBS	NULL
before	NULL
extraction	NULL
.	NULL

Sedimented	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
lysis	NULL
containing	NULL
protease	NULL
inhibitors	NULL
(	NULL
5	NULL
)	NULL
and	NULL
phosphatase	NULL
inhibitors	NULL
(	NULL
sodium	NULL
vanadate	NULL
[	NULL
1	NULL
mM	NULL
]	NULL
,	NULL
P-nitrophenyl	NULL
phosphate	NULL
[	NULL
10	NULL
mM	NULL
]	NULL
,	NULL
B-glycerophosphate	NULL
[	NULL
10	NULL
mM	NULL
}	NULL
,	NULL
sodium	NULL
fluoride	NULL
[	NULL
5	NULL
mM	NULL
}	NULL
,	NULL
and	NULL
okadaic	NULL
acid	NULL
[	NULL
200	NULL
nM	NULL
]	NULL
)	NULL
.	NULL

After	NULL
microcentrifugation	NULL
,	NULL
cytoplasmic	NULL
fractions	NULL
were	NULL
collected	NULL
and	NULL
nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
in	NULL
hypertonic	NULL
buffer	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
5	NULL
)	NULL
.	NULL

EMSA	NULL
.	NULL

The	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
was	NULL
performed	NULL
with	NULL
4	NULL
pg	NULL
of	NULL
nuclear	NULL
extract	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
a	NULL
[	NULL
y-	NULL
``	NULL
°P	NULL
]	NULL
ATP-labeled	NULL
,	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
either	NULL
the	NULL
HIV-1	NULL
LTR	NULL
binding	NULL
site	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
5-ACAAGGGACTTTCCGCTGGGACTTTCCAGG	NULL
GA-3	NULL
'	NULL
)	NULL
or	NULL
the	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
Spl	NULL
(	NULL
5'-GGGAGGCGTGGCCTGGG	NULL
CGGGACTGGGGAGTGGC-3	NULL
'	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
analyzed	NULL
in	NULL
nondenaturing	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Competition	NULL
experiments	NULL
were	NULL
performed	NULL
by	NULL
adding	NULL
a	NULL
40	NULL
2932	NULL
-	NULL
JACOUE	NULL
ET	NULL
AL	NULL
.	NULL

fold	NULL
molar	NULL
excess	NULL
of	NULL
homologous	NULL
,	NULL
unlabeled	NULL
oligonucleotide	NULL
to	NULL
each	NULL
sample	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

Components	NULL
of	NULL
TNF-induced	NULL
DNA-binding	NULL
complexes	NULL
in	NULL
U1	NULL
nuclear	NULL
extracts	NULL
were	NULL
identified	NULL
by	NULL
incubation	NULL
with	NULL
specific	NULL
polyclonal	NULL
antibodies	NULL
directed	NULL
against	NULL
p50	NULL
or	NULL
p65	NULL
recombinant	NULL
protein	NULL
.	NULL

p50	NULL
antibodies	NULL
were	NULL
affinity-purified	NULL
immunoglobulins	NULL
obtained	NULL
from	NULL
an	NULL
immune	NULL
polyclonal	NULL
rabbit	NULL
serum	NULL
generated	NULL
by	NULL
immunization	NULL
with	NULL
recombinant	NULL
p50	NULL
.	NULL

p65	NULL
antibodies	NULL
were	NULL
affinity-purified	NULL
immunoglobulins	NULL
obtained	NULL
from	NULL
an	NULL
immune	NULL
polyclonal	NULL
rabbit	NULL
raised	NULL
again	NULL
a	NULL
peptide	NULL
corresponding	NULL
to	NULL
amino	NULL
acids	NULL
531	NULL
to	NULL
550	NULL
mapping	NULL
within	NULL
the	NULL
carboxy-terminal	NULL
region	NULL
of	NULL
human	NULL
p65	NULL
(	NULL
antibody	NULL
C20	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

Nuclear	NULL
run-on	NULL
assays	NULL
.	NULL

Isolation	NULL
of	NULL
nuclei	NULL
and	NULL
run-on	NULL
transcription	NULL
assays	NULL
were	NULL
performed	NULL
by	NULL
using	NULL
a	NULL
modification	NULL
(	NULL
39	NULL
)	NULL
of	NULL
the	NULL
original	NULL
procedure	NULL
(	NULL
23	NULL
)	NULL
.	NULL

To	NULL
prepare	NULL
nuclei	NULL
,	NULL
cells	NULL
were	NULL
quickly	NULL
disrupted	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
10	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
MgC	NULL
)	NULL
;	NULL
)	NULL
containing	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
and	NULL
layered	NULL
onto	NULL
30	NULL
%	NULL
sucrose	NULL
in	NULL
50	NULL
mM	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
8.2	NULL
]	NULL
-5	NULL
mM	NULL
MgCl	NULL
,	NULL
-0.1	NULL
mM	NULL
EDTA	NULL
.	NULL

Pelleted	NULL
nuclei	NULL
were	NULL
resuspended	NULL
and	NULL
stored	NULL
under	NULL
liquid	NULL
nitrogen	NULL
in	NULL
40	NULL
%	NULL
glycerol-50	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.2	NULL
)	NULL
-5	NULL
mM	NULL
MgCl	NULL
,	NULL
-0.1	NULL
mM	NULL
EDTA	NULL
.	NULL

Run-on	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
10	NULL
``	NULL
nuclei	NULL
incubated	NULL
with	NULL
[	NULL
«	NULL
-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
UTP	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
;	NULL
Am-ersham	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Labeled	NULL
RNAs	NULL
were	NULL
purified	NULL
by	NULL
using	NULL
Qiagen	NULL
columns	NULL
as	NULL
specified	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Labeled	NULL
RNAs	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
to	NULL
10	NULL
``	NULL
cpm	NULL
)	NULL
were	NULL
hybridized	NULL
for	NULL
3	NULL
days	NULL
at	NULL
50°C	NULL
with	NULL
linearized	NULL
,	NULL
denatured	NULL
plasmid	NULL
DNA	NULL
immobilized	NULL
on	NULL
nitrocellulose	NULL
membranes	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
)	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
washed	NULL
and	NULL
treated	NULL
with	NULL
RNase	NULL
A	NULL
(	NULL
100	NULL
mg/m	NULL
!	NULL
)	NULL

prior	NULL
to	NULL
autoradiography	NULL
.	NULL

Plasmids	NULL
probes	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
pLTRXluc	NULL
(	NULL
59	NULL
)	NULL
linearized	NULL
by	NULL
HindIII	NULL
(	NULL
fragment	NULL
size	NULL
,	NULL
80	NULL
bp	NULL
)	NULL
,	NULL
pLgagSN	NULL
containing	NULL
an	NULL
EcoRI-Bg/II	NULL
PCR-amplified	NULL
HIV-1	NULL
;	NULL
a	NULL
;	NULL
fragment	NULL
cloned	NULL
into	NULL
the	NULL
EcoRI-BamHI-digested	NULL
pLXSN	NULL
vector	NULL
and	NULL
linearized	NULL
by	NULL
EcoRI	NULL
(	NULL
fragment	NULL
size	NULL
,	NULL
1,500	NULL
bp	NULL
)	NULL
,	NULL
proviral	NULL
construct	NULL
pBru-2	NULL
(	NULL
44	NULL
)	NULL
linearized	NULL
by	NULL
BamHI	NULL
(	NULL
localized	NULL
in	NULL
the	NULL
env	NULL
sequence	NULL
)	NULL
(	NULL
fragment	NULL
size	NULL
,	NULL
8,063	NULL
bp	NULL
)	NULL
,	NULL
pB-actin	NULL
(	NULL
provided	NULL
by	NULL
A.	NULL
Hovanessian	NULL
)	NULL
containing	NULL
the	NULL
B-actin	NULL
cDNA	NULL
(	NULL
53	NULL
)	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
pGEM	NULL
and	NULL
linearized	NULL
outside	NULL
the	NULL
B-actin	NULL
cDNA	NULL
by	NULL
Xbal	NULL
(	NULL
fragment	NULL
size	NULL
,	NULL
1,170	NULL
bp	NULL
)	NULL
,	NULL
and	NULL
control	NULL
plasmid	NULL
pUcBM20	NULL
(	NULL
Boehringer	NULL
)	NULL
linearized	NULL
by	NULL
EcoRI	NULL
(	NULL
2,300	NULL
bp	NULL
)	NULL
.	NULL

Hybridization	NULL
background	NULL
was	NULL
estimated	NULL
by	NULL
probing	NULL
in	NULL
vitro	NULL
[	NULL
«	NULL
-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
UTP-labeled	NULL
RNAs	NULL
with	NULL
EcoRI-linearized	NULL
pUcBM20	NULL
.	NULL

Levels	NULL
of	NULL
in	NULL
vitro-transcribed	NULL
RNAs	NULL
was	NULL
estimated	NULL
after	NULL
2	NULL
to	NULL
3	NULL
days	NULL
of	NULL
exposure	NULL
by	NULL
scanning	NULL
the	NULL
membranes	NULL
with	NULL
a	NULL
digital	NULL
imaging	NULL
system	NULL
,	NULL
and	NULL
computer-generated	NULL
images	NULL
were	NULL
analyzed	NULL
to	NULL
obtain	NULL
densitometric	NULL
values	NULL
(	NULL
PhosphorImager	NULL
model	NULL
250	NULL
and	NULL
Molecular	NULL
Dynamics	NULL
program	NULL
)	NULL
.	NULL

Nucleic	NULL
acid	NULL
purification	NULL
and	NULL
PCR	NULL
analysis	NULL
.	NULL

As	NULL
described	NULL
previously	NULL
(	NULL
4	NULL
,	NULL
67	NULL
)	NULL
,	NULL
DNA	NULL
used	NULL
for	NULL
PCR	NULL
amplification	NULL
was	NULL
extracted	NULL
by	NULL
lysis	NULL
of	NULL
cells	NULL
in	NULL
urea	NULL
lysis	NULL
buffer	NULL
(	NULL
4.7	NULL
M	NULL
urea	NULL
,	NULL
1.3	NULL
%	NULL
[	NULL
wt/vol	NULL
]	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
,	NULL
0.23	NULL
M	NULL
NaCl	NULL
,	NULL
0.67	NULL
mM	NULL
EDTA	NULL
[	NULL
pH	NULL
8	NULL
]	NULL
,	NULL
6.7	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
8	NULL
]	NULL
)	NULL
,	NULL
extracted	NULL
with	NULL
phenol-chloroform	NULL
,	NULL
and	NULL
precipitated	NULL
in	NULL
ethanol	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
cell	NULL
cultures	NULL
by	NULL
using	NULL
TRIzol	NULL
reagent	NULL
as	NULL
specified	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
GibcoBRL	NULL
)	NULL
.	NULL

To	NULL
remove	NULL
all	NULL
traces	NULL
of	NULL
DNA	NULL
,	NULL
RNA	NULL
preparations	NULL
were	NULL
subjected	NULL
to	NULL
digestion	NULL
with	NULL
RNase-free	NULL
DNase	NULL
I	NULL
(	NULL
Boehringer	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

RNA	NULL
(	NULL
<	NULL
3	NULL
pg	NULL
)	NULL
was	NULL
subjected	NULL
to	NULL
hybridization	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
the	NULL
3	NULL
'	NULL
primer	NULL
(	NULL
antisense	NULL
)	NULL
,	NULL
and	NULL
first-strand	NULL
cDNA	NULL
synthesis	NULL
was	NULL
performed	NULL
with	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Superscript	NULL
;	NULL
GibcoBRL	NULL
)	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
;	NULL
5	NULL
to	NULL
10	NULL
pl	NULL
of	NULL
these	NULL
cDNA	NULL
products	NULL
was	NULL
subsequently	NULL
subjected	NULL
to	NULL
analysis	NULL
by	NULL
PCR	NULL
.	NULL

PCR	NULL
amplifications	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
67	NULL
)	NULL
,	NULL
using	NULL
50	NULL
ng	NULL
of	NULL
the	NULL
3	NULL
'	NULL
primer	NULL
and	NULL
25	NULL
ng	NULL
of	NULL
the	NULL
5	NULL
'	NULL
primer	NULL
(	NULL
sense	NULL
)	NULL
end	NULL
labeled	NULL
with	NULL
*P	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
to	NULL
10°	NULL
cpm	NULL
)	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
0.25	NULL
mM	NULL
each	NULL
of	NULL
the	NULL
four	NULL
deoxynucleoside	NULL
triphosphates	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
25	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8	NULL
)	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
100	NULL
pg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
1.5	NULL
U	NULL
of	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Unless	NULL
indicated	NULL
otherwise	NULL
,	NULL
amplification	NULL
conditions	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
5	NULL
min	NULL
of	NULL
incubation	NULL
at	NULL
94°C	NULL
followed	NULL
by	NULL
1	NULL
min	NULL
at	NULL
94°C	NULL
and	NULL
2	NULL
min	NULL
at	NULL
65°C	NULL
for	NULL
30	NULL
cycles	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
separated	NULL
by	NULL
gel	NULL
electrophoresis	NULL
on	NULL
6	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
visualized	NULL
by	NULL
direct	NULL
autoradiography	NULL
of	NULL
the	NULL
dried	NULL
gels	NULL
.	NULL

For	NULL
quantification	NULL
analysis	NULL
,	NULL
gels	NULL
were	NULL
recorded	NULL
with	NULL
a	NULL
digital	NULL
imaging	NULL
system	NULL
,	NULL
and	NULL
computer-generated	NULL
images	NULL
were	NULL
analyzed	NULL
to	NULL
obtain	NULL
densitometric	NULL
values	NULL
(	NULL
PhosphorImager	NULL
model	NULL
250	NULL
and	NULL
Molecular	NULL
Dynamics	NULL
program	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
RNA	NULL
species	NULL
was	NULL
estimated	NULL
by	NULL
using	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
original	NULL
method	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
PCR	NULL
amplification	NULL
products	NULL
were	NULL
removed	NULL
during	NULL
the	NULL
exponential	NULL
phase	NULL
of	NULL
the	NULL
PCR	NULL
.	NULL

Specific	NULL
RNA	NULL
signals	NULL
were	NULL
plotted	NULL
on	NULL
a	NULL
semilog	NULL
scale	NULL
against	NULL
the	NULL
number	NULL
of	NULL
cycles	NULL
,	NULL
and	NULL
quantitation	NULL
of	NULL
a	NULL
given	NULL
RNA	NULL
species	NULL
was	NULL
obtained	NULL
by	NULL
extrapolation	NULL
to	NULL
the	NULL
zero	NULL
cycle	NULL
.	NULL

The	NULL
PCR	NULL
primers	NULL
of	NULL
HIV-1	NULL
used	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
1	NULL
,	NULL
4	NULL
,	NULL
67	NULL
)	NULL
.	NULL

For	NULL
HIV-1	NULL
DNA	NULL
detection	NULL
,	NULL
primers	NULL
M667	NULL
(	NULL
5-GGCTAACTAGGGAACCCACTG-3	NULL
'	NULL
)	NULL
and	NULL
AA55	NULL
(	NULL
5-CTGCTAGAGATTTTCCACACTGAC-3	NULL
'	NULL
)	NULL
were	NULL
used	NULL
.	NULL

This	NULL
pair	NULL
amplifies	NULL
a	NULL
fragment	NULL
of	NULL
140	NULL
bp	NULL
.	NULL

Quantitation	NULL
of	NULL
HIV-1	NULL
DNA	NULL
was	NULL
performed	NULL
by	NULL
analyzing	NULL
a	NULL
standard	NULL
curve	NULL
of	NULL
dilutions	NULL
of	NULL
cloned	NULL
HIV-1	NULL
;	NULL
a	NULL
;	NULL
DNA	NULL
linearized	NULL
outside	NULL
viral	NULL
sequences	NULL
.	NULL

Use	NULL
of	NULL
a	NULL
pair	NULL
of	NULL
oligonucleotides	NULL
complementary	NULL
to	NULL
the	NULL
B-actin	NULL
cDNA	NULL
sequence	NULL
(	NULL
53	NULL
)	NULL
,	NULL
sense	NULL
(	NULL
5	NULL
%	NULL
-GTGGGGCGCCCCAGGCACCA-3	NULL
'	NULL
)	NULL
and	NULL
|	NULL
antisense	NULL
-	NULL
(	NULL
5'-CGGTTGGCCTTGGGGTTCAGGGGGG-3	NULL
'	NULL
)	NULL
,	NULL
yields	NULL
a	NULL
244-bp	NULL
amplified	NULL
product	NULL
.	NULL

The	NULL
oligonucleotide	NULL
primers	NULL
used	NULL
for	NULL
detection	NULL
of	NULL
total	NULL
HIV-1	NULL
RNAs	NULL
were	NULL
antisense	NULL
oligonucleotide	NULL
M668	NULL
(	NULL
4	NULL
)	NULL
(	NULL
5'-CGCGTCCCT	NULL
GTTCGGGCGCC-3	NULL
'	NULL
)	NULL
combined	NULL
with	NULL
M667	NULL
for	NULL
PCR	NULL
amplification	NULL
of	NULL
a	NULL
161-bp	NULL
product	NULL
.	NULL

Oligonucleotide	NULL
primers	NULL
LA45	NULL
(	NULL
sense	NULL
;	NULL
5-GGCITAGGCATCTC	NULL
CTATGGC-3	NULL
'	NULL
)	NULL
and	NULL
L¥41	NULL
(	NULL
antisense	NULL
;	NULL
5-TGTCGGGTCCCCTCGTTGCTGG-3	NULL
'	NULL
)	NULL
(	NULL
4	NULL
)	NULL
allowed	NULL
the	NULL
detection	NULL
of	NULL
a	NULL
123-bp	NULL
PCR	NULL
product	NULL
specific	NULL
for	NULL
HIV-1	NULL
tat/rev	NULL
spliced	NULL
RNA	NULL
.	NULL

Nested	NULL
PCR	NULL
was	NULL
performed	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
HIV-1	NULL
RNAs	NULL
prepared	NULL
from	NULL
U937	NULL
cells	NULL
infected	NULL
with	NULL
wt	NULL
and	NULL
«	NULL
B-Mut	NULL
constructs	NULL
.	NULL

The	NULL
outer	NULL
primers	NULL
were	NULL
M661	NULL
J.	NULL
Virou	NULL
.	NULL

NF-xB	NULL
probe	NULL
Sp1	NULL
probe	NULL
TNF	NULL
-	NULL
2h	NULL
Sh	NULL
2h	NULL
2h	NULL
TNF	NULL
(	NULL
2h	NULL
)	NULL
TNF	NULL
=	NULL
2h	NULL
Sh	NULL
2h	NULL
2h	NULL
!	NULL

~	NULL
-a	NULL
a	NULL
)	NULL
chase	NULL
.	NULL

-	NULL
-	NULL
-	NULL
6hok	NULL
_§§_	NULL
chase	NULL
6	NULL
-	NULL
&	NULL
6h	NULL
»	NULL
competitor	NULL
808	NULL
-	NULL
-	NULL
+	NULL
-	NULL
Bo	NULL
S	NULL
S	NULL
-	NULL
competitor	NULL
|	NULL
=	NULL
-	NULL
-	NULL
-	NULL
+	NULL
so	NULL
:	NULL
-	NULL
-b	NULL
WWW	NULL
-	NULL
»	NULL
NFxB	NULL
-	NULL
i	NULL
'	NULL
NExB	NULL
-I	NULL
“	NULL
-102	NULL
3	NULL
4	NULL
5	NULL
607	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Inhibition	NULL
of	NULL
TNF-induced	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
in	NULL
U1	NULL
cells	NULL
.	NULL

U1	NULL
cells	NULL
were	NULL
exposed	NULL
for	NULL
2	NULL
h	NULL
to	NULL
TNF	NULL
and	NULL
then	NULL
extensively	NULL
washed	NULL
in	NULL
prewarmed	NULL
PBS	NULL
.	NULL

Aliquots	NULL
were	NULL
processed	NULL
to	NULL
obtain	NULL
nuclear	NULL
extracts	NULL
,	NULL
nuclei	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
,	NULL
and	NULL
total	NULL
RNA	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
remaining	NULL
cells	NULL
were	NULL
reseeded	NULL
in	NULL
fresh	NULL
culture	NULL
medium	NULL
in	NULL
either	NULL
the	NULL
absence	NULL
(	NULL
chase	NULL
)	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
TNF	NULL
for	NULL
an	NULL
additional	NULL
6	NULL
h.	NULL
EMSA	NULL
was	NULL
done	NULL
with	NULL
4	NULL
pg	NULL
of	NULL
nuclear	NULL
extracts	NULL
and	NULL
oligonucleotides	NULL
representing	NULL
xB	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
9	NULL
)	NULL
and	NULL
Sp1	NULL
(	NULL
lanes	NULL
10	NULL
to	NULL
14	NULL
)	NULL
motifs	NULL
.	NULL

Competition	NULL
with	NULL
a	NULL
40-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
was	NULL
used	NULL
to	NULL
confirm	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
DNA-binding	NULL
activity	NULL
detected	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
14	NULL
)	NULL
.	NULL

Anti-p63	NULL
and	NULL
-p50	NULL
(	NULL
«	NULL
p65	NULL
and	NULL
«	NULL
p50	NULL
)	NULL
polyclonal	NULL
rabbit	NULL
antisera	NULL
or	NULL
rabbit	NULL
preim-mune	NULL
serum	NULL
(	NULL
PT	NULL
;	NULL
1	NULL
pl	NULL
)	NULL
was	NULL
added	NULL
with	NULL
the	NULL
sample	NULL
15	NULL
min	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
the	NULL
radiolabeled	NULL
xB	NULL
probe	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
)	NULL
.	NULL

(	NULL
67	NULL
)	NULL
(	NULL
antisense	NULL
;	NULL
(	NULL
5	NULL
%	NULL
-CCTGCGAGAGAGCTCCTCTGG-3	NULL
'	NULL
)	NULL
and	NULL
ST1	NULL
(	NULL
1	NULL
)	NULL
(	NULL
sense	NULL
;	NULL
5-GGGTCTCTCTGGTTAGA-3	NULL
'	NULL
)	NULL
,	NULL
while	NULL
the	NULL
inner	NULL
primer	NULL
pair	NULL
was	NULL
M667-M668	NULL
.	NULL

Three	NULL
microliters	NULL
of	NULL
the	NULL
first-round	NULL
nonlabeled	NULL
products	NULL
was	NULL
used	NULL
as	NULL
the	NULL
template	NULL
for	NULL
the	NULL
second	NULL
amplification	NULL
reaction	NULL
.	NULL

Low-molecular-weight	NULL
DNA	NULL
extraction	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
5	NULL
)	NULL
.	NULL

DNA	NULL
extracted	NULL
from	NULL
cell	NULL
nuclei	NULL
isolated	NULL
30	NULL
min	NULL
after	NULL
transfection	NULL
was	NULL
analyzed	NULL
quantitatively	NULL
after	NULL
transfer	NULL
of	NULL
serial	NULL
dilutions	NULL
onto	NULL
a	NULL
nylon	NULL
membrane	NULL
(	NULL
Amersham	NULL
)	NULL
and	NULL
hybridization	NULL
with	NULL
a	NULL
y-*°P-labeled	NULL
HIV-1	NULL
gag	NULL
probe	NULL
.	NULL

RESULTS	NULL
U1	NULL
cells	NULL
pulsed	NULL
by	NULL
TNF	NULL
and	NULL
then	NULL
maintained	NULL
in	NULL
its	NULL
absence	NULL
exhibit	NULL
transient	NULL
expression	NULL
of	NULL
nuclear	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
contribution	NULL
of	NULL
activated	NULL
NF-kB	NULL
factor	NULL
to	NULL
the	NULL
ongoing	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
endogenous	NULL
HIV-1	NULL
LTR	NULL
in	NULL
TNF-treated	NULL
U1	NULL
cells	NULL
,	NULL
we	NULL
used	NULL
a	NULL
recently	NULL
described	NULL
(	NULL
3	NULL
)	NULL
experimental	NULL
system	NULL
in	NULL
which	NULL
induction	NULL
of	NULL
early	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
results	NULL
in	NULL
a	NULL
transient	NULL
expression	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
,	NULL
followed	NULL
by	NULL
its	NULL
early	NULL
disappearance	NULL
from	NULL
the	NULL
nuclear	NULL
compartment	NULL
.	NULL

U1	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
TNF	NULL
(	NULL
pulse	NULL
)	NULL
and	NULL
cultured	NULL
for	NULL
6	NULL
h	NULL
in	NULL
its	NULL
absence	NULL
(	NULL
chase	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
these	NULL
experimental	NULL
conditions	NULL
resulted	NULL
in	NULL
transient	NULL
TNF-induced	NULL
NF-kB	NULL
binding	NULL
to	NULL
the	NULL
xB	NULL
motifs	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
,	NULL
since	NULL
this	NULL
complex	NULL
is	NULL
clearly	NULL
reduced	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
compared	NULL
with	NULL
its	NULL
binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
continuously	NULL
treated	NULL
with	NULL
TNF	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
NF-kB/DNA	NULL
complexes	NULL
detected	NULL
in	NULL
TNF-treated	NULL
U1	NULL
cells	NULL
was	NULL
proven	NULL
by	NULL
competition	NULL
with	NULL
unlabeled	NULL
DNA	NULL
oligonucleotides	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

From	NULL
results	NULL
of	NULL
assays	NULL
using	NULL
p65	NULL
and	NULL
p50	NULL
rabbit	NULL
polyclonal	NULL
antibodies	NULL
(	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
,	NULL
we	NULL
concluded	NULL
that	NULL
most	NULL
of	NULL
the	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
was	NULL
due	NULL
to	NULL
bona	NULL
fide	NULL
heterodimers	NULL
composed	NULL
by	NULL
p50	NULL
and	NULL
p65	NULL
proteins	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
primarily	NULL
NF-kB	NULL
was	NULL
affected	NULL
in	NULL
these	NULL
experimental	NULL
conditions	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Sp1	NULL
,	NULL
which	NULL
is	NULL
essential	NULL
for	NULL
HIV-1	NULL
LTR	NULL
transcriptional	NULL
activity	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
NF-kB	NULL
,	NULL
Sp1	NULL
DNA-binding	NULL
activity	NULL
was	NULL
constitutively	NULL
detectable	NULL
in	NULL
uninduced	NULL
cells	NULL
and	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
experiment	NULL
,	NULL
remained	NULL
unchanged	NULL
or	NULL
increased	NULL
slightly	NULL
upon	NULL
TNF	NULL
stimulation	NULL
(	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
.	NULL

While	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
is	NULL
clearly	NULL
reduced	NULL
following	NULL
transient	NULL
exposure	NULL
to	NULL
TNF	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
Spl	NULL
DNA-binding	NULL
activity	NULL
is	NULL
not	NULL
significantly	NULL
affected	NULL
(	NULL
compare	NULL
lane	NULL
13	NULL
with	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
.	NULL

Vou	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
A	NULL
[	NULL
-	NULL
]	NULL
control	NULL
TNF	NULL
(	NULL
2h	NULL
)	NULL
600	NULL
~	NULL
TNF	NULL
(	NULL
8h	NULL
)	NULL
BBZ	NULL
TNF	NULL
(	NULL
2h	NULL
)	NULL
/chase	NULL
(	NULL
6h	NULL
)	NULL
500	NULL
I	NULL
400	NULL
+	NULL
300	NULL
+	NULL
HIV-1	NULL
RNA	NULL
densitometric	NULL
signals	NULL
normalized	NULL
to	NULL
B-actin	NULL
RNA	NULL
(	NULL
arbitrary	NULL
units	NULL
)	NULL
.	NULL

L	NULL
LLL	NULL
P	NULL
L	NULL
L	NULL
LTP	NULL
o	NULL
-	NULL
As	NULL
B	NULL
HIV-LTR	NULL
HIV-gag	NULL
pBru-2	NULL
B	NULL
0	NULL
__	NULL
TNF	NULL
2h	NULL
-	NULL
TNF	NULL
8h	NULL
|	NULL
TNF	NULL
2h	NULL
chase	NULL
6h	NULL
M	NULL
-~	NULL
bpo	NULL
t	NULL
:	NULL
~y	NULL
wet	NULL
=	NULL
-	NULL
298	NULL
220	NULL
Hv	NULL
tue	NULL
#	NULL
<	NULL
2	NULL
,	NULL
total	NULL
RNA	NULL
#	NULL
»	NULL
«	NULL
-154	NULL
(	NULL
161	NULL
bp	NULL
)	NULL
8	NULL
-	NULL
134	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
0	NULL
12.6	NULL
92.8	NULL
28.2	NULL
HIV-1	NULL
RNA	NULL
densitometric	NULL
signals	NULL
(	NULL
arbitrary	NULL
units	NULL
)	NULL
.	NULL

FIG	NULL
.	NULL

2	NULL
.	NULL

The	NULL
decrease	NULL
of	NULL
HIV-1-LTR	NULL
transcriptional	NULL
activity	NULL
paralleled	NULL
the	NULL
diminution	NULL
of	NULL
TNF-induced-NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nuclear	NULL
run-on	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
nuclei	NULL
obtained	NULL
from	NULL
U1	NULL
cells	NULL
treated	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

In	NULL
vitro-labeled	NULL
nuclear	NULL
RNAs	NULL
were	NULL
hybridized	NULL
to	NULL
the	NULL
double-stranded	NULL
DNA	NULL
probes	NULL
indicated	NULL
below	NULL
the	NULL
columns	NULL
.	NULL

The	NULL
hybridization	NULL
signals	NULL
obtained	NULL
were	NULL
recorded	NULL
with	NULL
a	NULL
digital	NULL
imaging	NULL
system	NULL
.	NULL

The	NULL
densitometric	NULL
values	NULL
were	NULL
corrected	NULL
relatively	NULL
to	NULL
the	NULL
B-actin	NULL
values	NULL
and	NULL
are	NULL
expressed	NULL
in	NULL
arbitrary	NULL
units	NULL
for	NULL
each	NULL
series	NULL
of	NULL
HIV-1	NULL
fragments	NULL
.	NULL

The	NULL
data	NULL
show	NULL
a	NULL
representative	NULL
study	NULL
of	NULL
four	NULL
similar	NULL
independent	NULL
studies	NULL
.	NULL

(	NULL
B	NULL
)	NULL
RT-PCR	NULL
analysis	NULL
of	NULL
HIV-1	NULL
total	NULL
RNA	NULL
extracted	NULL
concomitantly	NULL
with	NULL
the	NULL
nuclear	NULL
extracts	NULL
analyzed	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Reactions	NULL
without	NULL
the	NULL
addition	NULL
of	NULL
reverse	NULL
transcriptase	NULL
(	NULL
-	NULL
)	NULL
were	NULL
used	NULL
to	NULL
control	NULL
contamination	NULL
of	NULL
RNA	NULL
samples	NULL
by	NULL
genomic	NULL
DNA	NULL
.	NULL

The	NULL
molecular	NULL
weight	NULL
marker	NULL
(	NULL
M	NULL
)	NULL
is	NULL
a	NULL
1-kb	NULL
ladder	NULL
;	NULL
positions	NULL
are	NULL
indicated	NULL
in	NULL
base	NULL
pairs	NULL
.	NULL

The	NULL
densitometric	NULL
values	NULL
obtained	NULL
from	NULL
the	NULL
digital	NULL
record	NULL
of	NULL
the	NULL
dried	NULL
gel	NULL
are	NULL
given	NULL
below	NULL
the	NULL
gel	NULL
.	NULL

Down-regulation	NULL
of	NULL
HIV-1	NULL
LTR	NULL
transcriptional	NULL
activity	NULL
parallels	NULL
the	NULL
decrease	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
in	NULL
TNF-pulsed	NULL
U1	NULL
cells	NULL
.	NULL

We	NULL
tested	NULL
whether	NULL
the	NULL
TNF-induced	NULL
HIV-1	NULL
LTR	NULL
transcriptional	NULL
activity	NULL
paralleled	NULL
the	NULL
transient	NULL
expression	NULL
of	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
.	NULL

The	NULL
rate	NULL
of	NULL
endogenous	NULL
HIV-1	NULL
proviral	NULL
transcription	NULL
was	NULL
assessed	NULL
by	NULL
nuclear	NULL
run-on	NULL
analysis	NULL
in	NULL
TNF-pulsed	NULL
U1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
[	NULL
«	NULL
-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
JUTP-labeled	NULL
nuclear	NULL
RNAs	NULL
were	NULL
hybridized	NULL
to	NULL
immobilized	NULL
HIV-1	NULL
DNA	NULL
fragments	NULL
(	NULL
Xhol-HindIII	NULL
fragment	NULL
of	NULL
the	NULL
LTR	NULL
,	NULL
gag	NULL
sequence	NULL
,	NULL
and	NULL
a	NULL
pBru-2	NULL
subgenomic	NULL
fragment	NULL
linearized	NULL
in	NULL
the	NULL
env	NULL
sequence	NULL
)	NULL
.	NULL

In	NULL
vitro-labeled	NULL
nuclear	NULL
RNAs	NULL
were	NULL
probed	NULL
with	NULL
B-actin	NULL
DNA	NULL
to	NULL
ensure	NULL
that	NULL
transcriptional	NULL
activity	NULL
of	NULL
this	NULL
cellular	NULL
gene	NULL
was	NULL
insensitive	NULL
to	NULL
the	NULL
experimental	NULL
conditions	NULL
used	NULL
.	NULL

The	NULL
hybridization	NULL
signals	NULL
obtained	NULL
with	NULL
the	NULL
three	NULL
different	NULL
HIV-1	NULL
DNA	NULL
probes	NULL
were	NULL
recorded	NULL
by	NULL
using	NULL
a	NULL
digital	NULL
imaging	NULL
system	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
program	NULL
)	NULL
and	NULL
normalized	NULL
relative	NULL
to	NULL
the	NULL
B-actin	NULL
standard	NULL
.	NULL

Corrected	NULL
densitometric	NULL
values	NULL
for	NULL
the	NULL
three	NULL
sets	NULL
of	NULL
in	NULL
vitro-transcribed	NULL
HIV-1	NULL
RNA	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
newly	NULL
synthesized	NULL
HIV-1	NULL
RNA	NULL
in	NULL
cells	NULL
continuously	NULL
exposed	NULL
to	NULL
TNF	NULL
for	NULL
2	NULL
or	NULL
8	NULL
h	NULL
paralleled	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
analyzed	NULL
above	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
above	NULL
,	NULL
the	NULL
EMSA	NULL
PERSISTENT	NULL
REPLICATION	NULL
OF	NULL
HIV-1	NULL
IN	NULL
MONOCYTES	NULL
REQUIRES	NULL
NF-	NULL
«	NULL
B	NULL
2933	NULL
experiments	NULL
revealed	NULL
a	NULL
clear	NULL
diminution	NULL
of	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
when	NULL
TNF	NULL
was	NULL
removed	NULL
after	NULL
a	NULL
2-h	NULL
pulse	NULL
followed	NULL
by	NULL
a	NULL
6-h	NULL
chase	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
;	NULL
compare	NULL
lane	NULL
4	NULL
with	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Nuclear	NULL
run-on	NULL
assays	NULL
were	NULL
performed	NULL
to	NULL
analyze	NULL
the	NULL
transcriptional	NULL
status	NULL
of	NULL
HIV-1	NULL
genome	NULL
expression	NULL
during	NULL
this	NULL
transient	NULL
TNF-induced	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
.	NULL

The	NULL
rates	NULL
of	NULL
de	NULL
novo	NULL
LTR	NULL
and	NULL
pBru-2	NULL
subgenomic	NULL
fragment	NULL
transcription	NULL
in	NULL
TNF-pulsed	NULL
U1	NULL
cells	NULL
were	NULL
reduced	NULL
by	NULL
32	NULL
and	NULL
52	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
compared	NULL
with	NULL
those	NULL
observed	NULL
in	NULL
controls	NULL
continuously	NULL
stimulated	NULL
with	NULL
TNF	NULL
for	NULL
8	NULL
h.	NULL
Figure	NULL
2A	NULL
shows	NULL
that	NULL
ongoing	NULL
HIV-1	NULL
transcription	NULL
induced	NULL
by	NULL
a	NULL
2-h	NULL
TNF	NULL
exposure	NULL
decreased	NULL
during	NULL
the	NULL
chase	NULL
period	NULL
[	NULL
TNF	NULL
(	NULL
2	NULL
h/chase	NULL
(	NULL
6	NULL
h	NULL
)	NULL
]	NULL
in	NULL
contrast	NULL
to	NULL
its	NULL
further	NULL
increase	NULL
when	NULL
TNF	NULL
was	NULL
maintained	NULL
in	NULL
the	NULL
culture	NULL
medium	NULL
[	NULL
TNF	NULL
(	NULL
8	NULL
h	NULL
)	NULL
]	NULL
.	NULL

The	NULL
ongoing	NULL
HIV-1	NULL
transcription	NULL
observed	NULL
during	NULL
the	NULL
chase	NULL
period	NULL
was	NULL
significantly	NULL
higher	NULL
than	NULL
after	NULL
a	NULL
2-h	NULL
exposure	NULL
to	NULL
TNF	NULL
,	NULL
probably	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
residual	NULL
LTR	NULL
transcriptional	NULL
activity	NULL
.	NULL

The	NULL
apparent	NULL
differences	NULL
between	NULL
RNA	NULL
levels	NULL
in	NULL
pulse-chase	NULL
experiments	NULL
and	NULL
in	NULL
cells	NULL
treated	NULL
for	NULL
2	NULL
h	NULL
alone	NULL
for	NULL
pBru-2	NULL
likely	NULL
reflect	NULL
experimental	NULL
variability	NULL
.	NULL

These	NULL
experiments	NULL
demonstrate	NULL
the	NULL
same	NULL
trend	NULL
as	NULL
for	NULL
the	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
observed	NULL
in	NULL
the	NULL
nuclei	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
and	NULL
were	NULL
confirmed	NULL
by	NULL
the	NULL
analysis	NULL
of	NULL
steady-state	NULL
levels	NULL
of	NULL
total	NULL
HIV-1	NULL
RNA	NULL
by	NULL
reverse	NULL
transcription-PCR	NULL
(	NULL
RT-PCR	NULL
)	NULL
.	NULL

To	NULL
maximize	NULL
detection	NULL
of	NULL
total	NULL
HIV-1	NULL
RNA	NULL
,	NULL
a	NULL
modified	NULL
PCR	NULL
method	NULL
using	NULL
y-°°P-labeled	NULL
specific	NULL
oligonucleotide	NULL
primers	NULL
for	NULL
amplification	NULL
was	NULL
used	NULL
;	NULL
this	NULL
procedure	NULL
was	NULL
followed	NULL
by	NULL
direct	NULL
autoradiography	NULL
of	NULL
the	NULL
gel-resolved	NULL
products	NULL
.	NULL

RT-PCR	NULL
products	NULL
of	NULL
B-actin	NULL
were	NULL
used	NULL
to	NULL
normalize	NULL
the	NULL
amount	NULL
of	NULL
HIV-1	NULL
cDNA	NULL
.	NULL

As	NULL
expected	NULL
from	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
transcriptional	NULL
activity	NULL
,	NULL
increased	NULL
amounts	NULL
of	NULL
total	NULL
HIV-1	NULL
RNA	NULL
were	NULL
observed	NULL
in	NULL
cells	NULL
continuously	NULL
treated	NULL
with	NULL
TNF	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
;	NULL
compare	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
with	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Total	NULL
HIV-1	NULL
RNA	NULL
amounts	NULL
observed	NULL
during	NULL
the	NULL
chase	NULL
period	NULL
were	NULL
clearly	NULL
lower	NULL
than	NULL
those	NULL
seen	NULL
in	NULL
8-h	NULL
TNF-treated	NULL
control	NULL
cells	NULL
.	NULL

They	NULL
were	NULL
significantly	NULL
higher	NULL
than	NULL
HIV-1	NULL
RNA	NULL
levels	NULL
in	NULL
cells	NULL
exposed	NULL
for	NULL
2	NULL
h	NULL
to	NULL
TNF	NULL
,	NULL
as	NULL
expected	NULL
from	NULL
the	NULL
ongoing	NULL
accumulation	NULL
of	NULL
viral	NULL
RNAs	NULL
from	NULL
the	NULL
residual	NULL
LTR	NULL
transcriptional	NULL
activity	NULL
.	NULL

Inhibition	NULL
of	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
in	NULL
chronically	NULL
infected	NULL
U937	NULL
cells	NULL
is	NULL
sufficient	NULL
to	NULL
reduce	NULL
levels	NULL
of	NULL
steady-state	NULL
HIV-1	NULL
RNA	NULL
.	NULL

We	NULL
established	NULL
previously	NULL
that	NULL
chronic	NULL
HIV-1	NULL
replication	NULL
in	NULL
the	NULL
monocytic	NULL
cell	NULL
line	NULL
U937	NULL
induces	NULL
permanent	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
heterodimers	NULL
(	NULL
pS50/p65	NULL
)	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
could	NULL
have	NULL
functional	NULL
effects	NULL
on	NULL
endogenous	NULL
HIV-1	NULL
transcriptional	NULL
activity	NULL
,	NULL
despite	NULL
the	NULL
production	NULL
of	NULL
the	NULL
HIV-1	NULL
Tat	NULL
protein	NULL
,	NULL
the	NULL
transactivating	NULL
function	NULL
of	NULL
which	NULL
is	NULL
clearly	NULL
detected	NULL
in	NULL
these	NULL
infected	NULL
cultures	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Signal-induced	NULL
IxBa	NULL
degradation	NULL
,	NULL
which	NULL
leads	NULL
to	NULL
NF-kB	NULL
activation	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
the	NULL
proteolytic	NULL
activity	NULL
of	NULL
the	NULL
proteasome	NULL
(	NULL
13	NULL
,	NULL
46	NULL
,	NULL
55	NULL
,	NULL
63	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
this	NULL
HIV	NULL
-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
ultimately	NULL
mediated	NULL
by	NULL
the	NULL
proteasome	NULL
through	NULL
degradation	NULL
or	NULL
processing	NULL
of	NULL
NF-kB	NULL
inhibitors	NULL
,	NULL
we	NULL
treated	NULL
HIV-1-infected	NULL
U937	NULL
cells	NULL
continuously	NULL
with	NULL
the	NULL
peptide	NULL
aldehyde	NULL
Z-LLL-H	NULL
,	NULL
which	NULL
specifically	NULL
blocks	NULL
the	NULL
proteolytic	NULL
activity	NULL
of	NULL
the	NULL
proteasome	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Control	NULL
,	NULL
uninfected	NULL
U937	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
peptide	NULL
aldehyde	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
TNF	NULL
for	NULL
10	NULL
min	NULL
prior	NULL
to	NULL
cell	NULL
extraction	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
8	NULL
to	NULL
10	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
uninfected	NULL
U937	NULL
cells	NULL
with	NULL
either	NULL
1	NULL
or	NULL
10	NULL
wM	NULL
Z-LLL-H	NULL
reduced	NULL
TNF-induced	NULL
nuclear	NULL
NF-kB	NULL
complexes	NULL
since	NULL
the	NULL
residual	NULL
activity	NULL
observed	NULL
was	NULL
57	NULL
or	NULL
62.2	NULL
%	NULL
,	NULL
respectively	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
,	NULL
of	NULL
that	NULL
detected	NULL
in	NULL
untreated	NULL
cells	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
(	NULL
7	NULL
,	NULL
10	NULL
,	NULL
30	NULL
,	NULL
40	NULL
,	NULL
60	NULL
)	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
TNF-induced	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
paralleled	NULL
the	NULL
rapid	NULL
degradation	NULL
of	NULL
IxBa	NULL
and	NULL
that	NULL
pretreat-ment	NULL
with	NULL
compound	NULL
Z-LLL-H	NULL
blocked	NULL
the	NULL
TNF-induced	NULL
deg-	NULL
2934	NULL
__	NULL
JACOUE	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
HIV-infected	NULL
U937	NULL
cells	NULL
uninfected	NULL
U937	NULL
cells	NULL
TNF	NULL
0a	NULL
“	NULL
control	NULL
_	NULL
(	NULL
10min	NULL
)	NULL
TCA	NULL
MOI	NULL
Inhibitor	NULL
Z-LLL-H	NULL
(	NULL
M	NULL
)	NULL
_	NULL
0	NULL
1	NULL
10	NULL
0	NULL
A	NULL
f	NULL
10	NULL
0	NULL
1	NULL
10	NULL
«	NULL
«	NULL
-	NULL
-	NULL
O08	NULL
T	NULL
(	NULL
ib	NULL
uk	NULL
@	NULL
102	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8s	NULL
9	NULL
10	NULL
Sample	NULL
number	NULL
1°	NULL
2	NULL
3	NULL
8	NULL
9	NULL
10	NULL
Residual	NULL
NF-xB	NULL
100	NULL
58	NULL
41	NULL
100	NULL
57	NULL
62.2	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
%	NULL
)	NULL
B	NULL
100	NULL
7	NULL
90	NULL
80	NULL
+	NULL
70	NULL
+	NULL
60	NULL
+	NULL
50	NULL
+	NULL
ao	NULL
4	NULL
30	NULL
+	NULL
%	NULL
of	NULL
residual	NULL
HIV-1	NULL
RNA	NULL
as	NULL
compared	NULL
to	NULL
untreated	NULL
control	NULL
.	NULL

20	NULL
+	NULL
10	NULL
+	NULL
0	NULL
Z-LLL-H	NULL
(	NULL
uM	NULL
)	NULL
0	NULL
_	NULL
10	NULL
50	NULL
6	NULL
_	NULL
10	NULL
50	NULL
HIV	NULL
total	NULL
RNAs	NULL
HIV	NULL
tat/rev	NULL
RNA	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Inhibition	NULL
of	NULL
permanent	NULL
NF-kB	NULL
activation	NULL
by	NULL
the	NULL
peptide	NULL
aldehyde	NULL
Z-LLL-H	NULL
paralleled	NULL
the	NULL
diminution	NULL
of	NULL
endogenous	NULL
HIV-1	NULL
proviral	NULL
transcription	NULL
.	NULL

Infected	NULL
U937	NULL
cells	NULL
and	NULL
uninfected	NULL
controls	NULL
were	NULL
treated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
Z-LLL-H	NULL
,	NULL
and	NULL
the	NULL
uninfected	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
TNF	NULL
for	NULL
the	NULL
last	NULL
10	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
processed	NULL
to	NULL
obtain	NULL
nuclear	NULL
extracts	NULL
and	NULL
total	NULL
RNA	NULL
samples	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
using	NULL
extracts	NULL
from	NULL
infected	NULL
cells	NULL
(	NULL
>	NULL
30	NULL
days	NULL
after	NULL
infection	NULL
)	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
and	NULL
uninfected	NULL
control	NULL
cells	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
10	NULL
)	NULL
with	NULL
a	NULL
[	NULL
y-	NULL
``	NULL
°P	NULL
]	NULL
JATP-labeled	NULL
xB	NULL
oligonucleotide	NULL
.	NULL

Identically	NULL
prepared	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
cells	NULL
treated	NULL
with	NULL
Z-LLL-H	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
7	NULL
)	NULL
were	NULL
used	NULL
to	NULL
control	NULL
the	NULL
TNF-induced	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
(	NULL
lanes	NULL
8	NULL
to	NULL
10	NULL
)	NULL
.	NULL

Competition	NULL
(	NULL
Comp	NULL
)	NULL
was	NULL
performed	NULL
by	NULL
adding	NULL
a	NULL
40-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
unlabeled	NULL
oligonucleotide	NULL
to	NULL
each	NULL
sample	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
the	NULL
labeled	NULL
probe	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

The	NULL
residual	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
densitometric	NULL
analysis	NULL
of	NULL
the	NULL
autora-diogram	NULL
obtained	NULL
following	NULL
overnight	NULL
exposure	NULL
,	NULL
and	NULL
values	NULL
are	NULL
given	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Analysis	NULL
of	NULL
the	NULL
amounts	NULL
of	NULL
total	NULL
and	NULL
fat/rev	NULL
HIV-1	NULL
RNA	NULL
species	NULL
by	NULL
RT-PCR	NULL
from	NULL
infected	NULL
cells	NULL
treated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
Z-LLL-H	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
RNA	NULL
were	NULL
subjected	NULL
to	NULL
primer	NULL
extension	NULL
and	NULL
subsequent	NULL
PCR	NULL
analysis	NULL
with	NULL
HIV-1-	NULL
and	NULL
B-actin-specific	NULL
primers	NULL
.	NULL

Total	NULL
and	NULL
tat/revy	NULL
HIV-1	NULL
RNA	NULL
hybridization	NULL
signals	NULL
were	NULL
recorded	NULL
with	NULL
a	NULL
digital	NULL
imaging	NULL
system	NULL
.	NULL

The	NULL
densitometric	NULL
values	NULL
were	NULL
corrected	NULL
relative	NULL
to	NULL
the	NULL
B-actin	NULL
standards	NULL
and	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
residual	NULL
HIV-1	NULL
transcription	NULL
level	NULL
in	NULL
untreated	NULL
cells	NULL
.	NULL

These	NULL
percentages	NULL
of	NULL
residual	NULL
activity	NULL
were	NULL
plotted	NULL
versus	NULL
the	NULL
various	NULL
concentrations	NULL
of	NULL
Z-LLL-H	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
five	NULL
separate	NULL
similar	NULL
experiments	NULL
.	NULL

radation	NULL
of	NULL
IxBa	NULL
and	NULL
stabilized	NULL
phosphorylated	NULL
forms	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
same	NULL
treatment	NULL
was	NULL
applied	NULL
to	NULL
HIV-1l-infected	NULL
cells	NULL
.	NULL

Following	NULL
a	NULL
2-h	NULL
exposure	NULL
of	NULL
cells	NULL
to	NULL
Z-LLL-H	NULL
,	NULL
an	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
was	NULL
observed	NULL
.	NULL

Indeed	NULL
,	NULL
infected	NULL
cells	NULL
treated	NULL
with	NULL
either	NULL
1	NULL
or	NULL
10	NULL
wM	NULL
Z-LLL-H	NULL
showed	NULL
58	NULL
or	NULL
41	NULL
%	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
of	NULL
the	NULL
amount	NULL
of	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
detected	NULL
in	NULL
untreated	NULL
cells	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

We	NULL
next	NULL
analyzed	NULL
HIV-1	NULL
RNA	NULL
steady-state	NULL
levels	NULL
in	NULL
Z-LLL-H-treated	NULL
U937-infected	NULL
cells	NULL
by	NULL
the	NULL
RT-PCR	NULL
method	NULL
J.	NULL
ViroL	NULL
.	NULL

described	NULL
above	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Figure	NULL
3B	NULL
shows	NULL
residual	NULL
HIV-1	NULL
total	NULL
and	NULL
fat/rev	NULL
transcription	NULL
in	NULL
Z-LLL-H-treated	NULL
infected	NULL
cells	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
level	NULL
in	NULL
untreated	NULL
controls	NULL
cells	NULL
.	NULL

Levels	NULL
of	NULL
both	NULL
HIV-1	NULL
total	NULL
RNA	NULL
and	NULL
HIV-1	NULL
fat/rev	NULL
RNA	NULL
were	NULL
reduced	NULL
by	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
,	NULL
since	NULL
levels	NULL
of	NULL
residual	NULL
viral	NULL
transcription	NULL
were	NULL
,	NULL
respectively	NULL
,	NULL
38.6	NULL
and	NULL
48	NULL
%	NULL
(	NULL
10	NULL
wM	NULL
Z-LLL-H	NULL
)	NULL
and	NULL
23	NULL
and	NULL
42	NULL
%	NULL
(	NULL
50	NULL
wM	NULL
Z-LLL-H	NULL
)	NULL
of	NULL
the	NULL
control	NULL
levels	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
the	NULL
extent	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
inhibition	NULL
in	NULL
Z-LLL-H-treated	NULL
HIV-1-infected	NULL
cells	NULL
paralleled	NULL
the	NULL
decrease	NULL
of	NULL
integrated	NULL
provirus	NULL
transcription	NULL
,	NULL
which	NULL
suggests	NULL
that	NULL
maintenance	NULL
of	NULL
high-level	NULL
HIV-1	NULL
proviral	NULL
transcription	NULL
in	NULL
U937	NULL
monocytic	NULL
cells	NULL
depends	NULL
on	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
xB	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
down-regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
in	NULL
a	NULL
Tat-expressing	NULL
cell	NULL
environment	NULL
is	NULL
sufficient	NULL
to	NULL
cause	NULL
a	NULL
drastic	NULL
diminution	NULL
of	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
integrated	NULL
HIV-1	NULL
provirus	NULL
.	NULL

The	NULL
NF-KB	NULL
response	NULL
element	NULL
in	NULL
the	NULL
viral	NULL
enhancer	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
establishment	NULL
of	NULL
efficient	NULL
HIV-1	NULL
replication	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

To	NULL
analyze	NULL
directly	NULL
the	NULL
role	NULL
of	NULL
viral	NULL
enhancer	NULL
kB	NULL
sequences	NULL
in	NULL
the	NULL
establishment	NULL
of	NULL
HIV-1	NULL
replication	NULL
,	NULL
we	NULL
monitored	NULL
the	NULL
fate	NULL
of	NULL
«	NULL
<	NULL
B-Mut	NULL
virus	NULL
in	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

wt	NULL
and	NULL
HIV-1	NULL
constructs	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
28	NULL
)	NULL
and	NULL
differ	NULL
only	NULL
in	NULL
a	NULL
5-bp	NULL
substitution	NULL
(	NULL
AAGGG	NULL
to	NULL
TITAA	NULL
)	NULL
of	NULL
the	NULL
NF-kB	NULL
response	NULL
elements	NULL
in	NULL
both	NULL
the	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
LTRs	NULL
.	NULL

Kinetics	NULL
of	NULL
viral	NULL
replication	NULL
in	NULL
U937	NULL
cells	NULL
were	NULL
monitored	NULL
by	NULL
detection	NULL
of	NULL
p24°	NULL
``	NULL
°	NULL
production	NULL
.	NULL

After	NULL
the	NULL
onset	NULL
of	NULL
wt	NULL
virus	NULL
infection	NULL
,	NULL
levels	NULL
of	NULL
p24°**	NULL
production	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
observed	NULL
in	NULL
CEM	NULL
cells	NULL
infected	NULL
with	NULL
either	NULL
wt	NULL
or	NULL
xB-Mut	NULL
virus	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
clear	NULL
contrast	NULL
,	NULL
xB-Mut	NULL
viral	NULL
replication	NULL
was	NULL
impaired	NULL
in	NULL
U937	NULL
cells	NULL
,	NULL
with	NULL
10*-fold	NULL
less	NULL
virus	NULL
production	NULL
than	NULL
in	NULL
U937	NULL
cells	NULL
infected	NULL
with	NULL
wt	NULL
virus	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
different	NULL
infectivity	NULL
potentials	NULL
between	NULL
the	NULL
two	NULL
viral	NULL
preparations	NULL
could	NULL
account	NULL
for	NULL
their	NULL
different	NULL
replicative	NULL
patterns	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
HIV-1	NULL
proviral	NULL
DNA	NULL
synthesized	NULL
2	NULL
h	NULL
after	NULL
virus-cell	NULL
contact	NULL
was	NULL
examined	NULL
by	NULL
PCR	NULL
using	NULL
a	NULL
primer	NULL
pair	NULL
specific	NULL
for	NULL
the	NULL
R/US	NULL
region	NULL
,	NULL
which	NULL
should	NULL
detect	NULL
virtually	NULL
all	NULL
HIV-1	NULL
DNA	NULL
synthesized	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

An	NULL
oligonucleotide	NULL
pair	NULL
specific	NULL
for	NULL
the	NULL
human	NULL
B-actin	NULL
gene	NULL
was	NULL
used	NULL
to	NULL
estimate	NULL
the	NULL
amount	NULL
of	NULL
cellular	NULL
DNA	NULL
in	NULL
each	NULL
sample	NULL
.	NULL

Amounts	NULL
of	NULL
HIV-1	NULL
and	NULL
B-actin	NULL
DNAs	NULL
in	NULL
experimental	NULL
samples	NULL
were	NULL
estimated	NULL
by	NULL
comparison	NULL
with	NULL
standards	NULL
generated	NULL
with	NULL
known	NULL
amounts	NULL
of	NULL
either	NULL
cloned	NULL
HIV-1	NULL
;	NULL
4	NULL
;	NULL
DNA	NULL
or	NULL
U937	NULL
cellular	NULL
DNA	NULL
.	NULL

DNA	NULL
levels	NULL
were	NULL
recorded	NULL
with	NULL
a	NULL
digital	NULL
imaging	NULL
system	NULL
,	NULL
and	NULL
values	NULL
were	NULL
estimated	NULL
to	NULL
be	NULL
30	NULL
and	NULL
11	NULL
proviral	NULL
copies	NULL
for	NULL
cells	NULL
infected	NULL
with	NULL
the	NULL
wt	NULL
and	NULL
<	NULL
B-Mut	NULL
viruses	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
difference	NULL
between	NULL
DNA	NULL
levels	NULL
is	NULL
less	NULL
than	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
intensity	NULL
of	NULL
viral	NULL
replication	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
.	NULL

We	NULL
tested	NULL
whether	NULL
the	NULL
basal	NULL
transcriptional	NULL
capacity	NULL
of	NULL
both	NULL
proviral	NULL
constructs	NULL
could	NULL
have	NULL
accounted	NULL
for	NULL
the	NULL
replicative	NULL
defect	NULL
seen	NULL
with	NULL
the	NULL
«	NULL
B-Mut	NULL
virus	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

This	NULL
was	NULL
assessed	NULL
by	NULL
transient	NULL
transfection	NULL
of	NULL
U937	NULL
cells	NULL
with	NULL
the	NULL
wt	NULL
or	NULL
xB-Mut	NULL
proviral	NULL
construct	NULL
in	NULL
order	NULL
to	NULL
analyze	NULL
basal	NULL
LTR	NULL
transcriptional	NULL
activity	NULL
independently	NULL
of	NULL
viral	NULL
entry	NULL
and	NULL
proviral	NULL
inte-gration	NULL
.	NULL

Total	NULL
HIV-1	NULL
RNA	NULL
was	NULL
extracted	NULL
20	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
analyzed	NULL
by	NULL
RT-PCR	NULL
.	NULL

Total	NULL
HIV	NULL
RNA	NULL
signals	NULL
,	NULL
visualized	NULL
by	NULL
direct	NULL
autoradiography	NULL
of	NULL
the	NULL
dried	NULL
gel	NULL
,	NULL
were	NULL
recorded	NULL
,	NULL
and	NULL
densitometric	NULL
values	NULL
(	NULL
in	NULL
arbitrary	NULL
units	NULL
)	NULL
were	NULL
normalized	NULL
to	NULL
values	NULL
for	NULL
the	NULL
B-actin	NULL
standard	NULL
and	NULL
plasmid	NULL
DNA	NULL
entry	NULL
(	NULL
estimated	NULL
30	NULL
min	NULL
after	NULL
transfection	NULL
by	NULL
a	NULL
modified	NULL
Hirt	NULL
technique	NULL
)	NULL
.	NULL

The	NULL
provirus	NULL
was	NULL
not	NULL
less	NULL
transcrip-tionally	NULL
active	NULL
in	NULL
the	NULL
U937	NULL
cell	NULL
environment	NULL
than	NULL
its	NULL
wt	NULL
counterpart	NULL
(	NULL
26,383	NULL
and	NULL
8,943	NULL
arbitrary	NULL
units	NULL
of	NULL
HIV-1	NULL
RNA	NULL
syn-thesized	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Up-regulation	NULL
of	NULL
HIV-1	NULL
RNA	NULL
synthesis	NULL
was	NULL
observed	NULL
when	NULL
wt-	NULL
but	NULL
not	NULL
«	NULL
B-Mut-transfected	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
TNF	NULL
for	NULL
4	NULL
h	NULL
,	NULL
as	NULL
expected	NULL
for	NULL
a	NULL
provirus	NULL
lacking	NULL
the	NULL
voL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
A	NULL
106	NULL
10	NULL
E	NULL
)	NULL
10°	NULL
-*-	NULL
Wi-infected	NULL
cells	NULL
&	NULL
-L-	NULL
B-Mut-infected	NULL
cells	NULL
3	NULL
&	NULL
3	NULL
10	NULL
%	NULL
}	NULL
€	NULL
a	NULL
bo	NULL
3L	NULL
Ea	NULL
10	NULL
=	NULL
of	NULL
a	NULL
iz	NULL
s	NULL
.	NULL

2	NULL
1054	NULL
5	NULL
H	NULL
B	NULL
&	NULL
<	NULL
/	NULL
104	NULL
1	NULL
u	NULL
+	NULL
a	NULL
t	NULL
+	NULL
+	NULL
+	NULL
0	NULL
5	NULL
10	NULL
15	NULL
20	NULL
25	NULL
30	NULL
35	NULL
40	NULL
45	NULL
Days	NULL
after	NULL
infection	NULL
B	NULL
B-actin	NULL
Stds	NULL
HILV-1	NULL
Stds	NULL
(	NULL
no	NULL
.	NULL

of	NULL
cells	NULL
)	NULL
(	NULL
copies	NULL
)	NULL
A	NULL
&	NULL
©	NULL
105	NULL
104	NULL
103	NULL
m	NULL
9°	NULL
s	NULL
é	NULL
$	NULL
1	NULL
3	NULL
$	NULL
LCCC	NULL
#	NULL
£	NULL
M	NULL
46	NULL
g	NULL
#	NULL
&	NULL
Bactingie-	NULL
ﬁ	NULL
lw	NULL
|	NULL
220	NULL
,	NULL
201	NULL
52	NULL
:	NULL
HIV-1	NULL
(	NULL
140	NULL
bp	NULL
)	NULL
long	NULL
exposure	NULL
220	NULL
201	NULL
``	NULL
|	NULL
®	NULL
154	NULL
.	NULL

134-	NULL
|	NULL
&	NULL
us	NULL
t	NULL
dug	NULL
75-	NULL
|_	NULL
Wt	NULL
short	NULL
exposure	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Establishment	NULL
of	NULL
HIV-1	NULL
replication	NULL
in	NULL
U937	NULL
cells	NULL
is	NULL
dependent	NULL
on	NULL
«	NULL
B-responsive	NULL
elements	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
viral	NULL
supernatants	NULL
produced	NULL
after	NULL
50	NULL
days	NULL
of	NULL
culture	NULL
of	NULL
either	NULL
wt	NULL
or	NULL
xB-Mut	NULL
proviral	NULL
DNA-electropo-rated	NULL
CEM	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
similar	NULL
studies	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Viral	NULL
replication	NULL
was	NULL
determined	NULL
at	NULL
the	NULL
indicated	NULL
time	NULL
intervals	NULL
by	NULL
the	NULL
detection	NULL
of	NULL
p24®	NULL
``	NULL
``	NULL
antigen	NULL
in	NULL
the	NULL
culture	NULL
medium	NULL
,	NULL
and	NULL
values	NULL
were	NULL
plotted	NULL
on	NULL
a	NULL
semiloga-rithmic	NULL
scale	NULL
versus	NULL
time	NULL
after	NULL
infection	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Analysis	NULL
of	NULL
viral	NULL
and	NULL
cellular	NULL
DNA	NULL
by	NULL
PCR	NULL
performed	NULL
on	NULL
DNA	NULL
samples	NULL
corresponding	NULL
to	NULL
10°	NULL
cell	NULL
equivalents	NULL
.	NULL

Samples	NULL
were	NULL
taken	NULL
from	NULL
a	NULL
2-h-infected	NULL
U937	NULL
cell	NULL
culture	NULL
.	NULL

Standard	NULL
amounts	NULL
of	NULL
HIV-1	NULL
;	NULL
a	NULL
;	NULL
proviral	NULL
DNA	NULL
(	NULL
HIV-1	NULL
Stds	NULL
[	NULL
number	NULL
of	NULL
copies	NULL
]	NULL
)	NULL
and	NULL
U937	NULL
cell	NULL
DNA	NULL
(	NULL
B-actin	NULL
Stds	NULL
[	NULL
number	NULL
of	NULL
cells	NULL
]	NULL
)	NULL
were	NULL
amplified	NULL
in	NULL
parallel	NULL
.	NULL

Assessment	NULL
of	NULL
HIV-1	NULL
standards	NULL
after	NULL
a	NULL
shorter	NULL
exposure	NULL
of	NULL
the	NULL
dried	NULL
gel	NULL
is	NULL
shown	NULL
in	NULL
the	NULL
lower	NULL
panel	NULL
.	NULL

Lane	NULL
M	NULL
,	NULL
size	NULL
marker	NULL
(	NULL
positions	NULL
are	NULL
indicated	NULL
in	NULL
base	NULL
pairs	NULL
)	NULL
.	NULL

TNF-responsive	NULL
«	NULL
kB	NULL
elements	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
the	NULL
failure	NULL
of	NULL
<	NULL
B-Mut	NULL
provirus	NULL
to	NULL
achieve	NULL
productive	NULL
replication	NULL
in	NULL
U937	NULL
cells	NULL
seems	NULL
not	NULL
to	NULL
be	NULL
a	NULL
consequence	NULL
of	NULL
impaired	NULL
transcriptional	NULL
activity	NULL
or	NULL
a	NULL
lower	NULL
input	NULL
of	NULL
infectious	NULL
particles	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
underlined	NULL
the	NULL
critical	NULL
requirement	NULL
of	NULL
the	NULL
enhancer	NULL
kB	NULL
motifs	NULL
for	NULL
full	NULL
replication	NULL
in	NULL
monocytic	NULL
U937	NULL
cells	NULL
.	NULL

The	NULL
proteasome-mediated	NULL
regulation	NULL
of	NULL
NF-KB	NULL
affects	NULL
specifically	NULL
B-dependent	NULL
HIV-1	NULL
transcription	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
U937	NULL
cells	NULL
,	NULL
we	NULL
measured	NULL
its	NULL
effects	NULL
on	NULL
the	NULL
fate	NULL
of	NULL
steady-state	NULL
HIV-1	NULL
RNA	NULL
levels	NULL
in	NULL
wt-	NULL
and	NULL
<	NULL
B-Mut-infected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Both	NULL
cell	NULL
populations	NULL
were	NULL
treated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
various	NULL
amounts	NULL
of	NULL
the	NULL
compound	NULL
Z-LLL-H	NULL
before	NULL
harvesting	NULL
of	NULL
RNA	NULL
.	NULL

When	NULL
we	NULL
analyzed	NULL
HIV-1	NULL
RNAs	NULL
by	NULL
a	NULL
classic	NULL
RT-PCR	NULL
experimental	NULL
approach	NULL
in	NULL
<	NULL
B-Mut-infected	NULL
U937	NULL
cells	NULL
,	NULL
a	NULL
very	NULL
weak	NULL
amplification	NULL
was	NULL
observed	NULL
.	NULL

This	NULL
finding	NULL
was	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
undetectable	NULL
viral	NULL
replication	NULL
observed	NULL
in	NULL
these	NULL
infected	NULL
cells	NULL
as	NULL
measured	NULL
by	NULL
p24°	NULL
``	NULL
antigen	NULL
production	NULL
.	NULL

To	NULL
overcome	NULL
this	NULL
problem	NULL
,	NULL
we	NULL
used	NULL
a	NULL
more	NULL
sensitive	NULL
nested	NULL
PCR	NULL
technique	NULL
on	NULL
the	NULL
reverse-transcribed	NULL
HIV-1	NULL
RNA	NULL
.	NULL

RT-PCR	NULL
products	NULL
of	NULL
B-actin	NULL
were	NULL
used	NULL
to	NULL
normalize	NULL
the	NULL
amount	NULL
of	NULL
PERSISTENT	NULL
REPLICATION	NULL
OF	NULL
HIV-1	NULL
IN	NULL
MONOCYTES	NULL
REQUIRES	NULL
NF-	NULL
«	NULL
B	NULL
2935	NULL
HIV-1	NULL
cDNA	NULL
used	NULL
as	NULL
the	NULL
template	NULL
for	NULL
the	NULL
PCR	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
a	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
total	NULL
HIV-1	NULL
RNA	NULL
levels	NULL
was	NULL
observed	NULL
in	NULL
extracts	NULL
from	NULL
wt-infected-cells	NULL
treated	NULL
with	NULL
Z-LLL-H	NULL
.	NULL

The	NULL
total	NULL
HIV-1	NULL
RNA	NULL
signals	NULL
visualized	NULL
by	NULL
direct	NULL
autoradiography	NULL
of	NULL
dried	NULL
gels	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
and	NULL
B	NULL
)	NULL
were	NULL
quantified	NULL
.	NULL

Densitometric	NULL
values	NULL
were	NULL
expressed	NULL
as	NULL
percentages	NULL
of	NULL
the	NULL
value	NULL
for	NULL
HIV-1	NULL
residual	NULL
transcription	NULL
in	NULL
corresponding	NULL
untreated	NULL
controls	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

In	NULL
Z-LLL-H-treated	NULL
cells	NULL
,	NULL
residual	NULL
HIV-1	NULL
transcription	NULL
represented	NULL
30	NULL
%	NULL
of	NULL
the	NULL
level	NULL
in	NULL
untreated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
)	NULL
.	NULL

At	NULL
this	NULL
concentration	NULL
of	NULL
the	NULL
inhibitor	NULL
(	NULL
50	NULL
M	NULL
)	NULL
,	NULL
we	NULL
observed	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
amount	NULL
of	NULL
total	NULL
HIV-1	NULL
RNA	NULL
accumulated	NULL
in	NULL
the	NULL
«	NULL
<	NULL
B-Mut-infected	NULL
U937	NULL
population	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
effects	NULL
of	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
Z-LLL-H	NULL
on	NULL
the	NULL
steady-state	NULL
levels	NULL
of	NULL
total	NULL
HIV-1	NULL
RNA	NULL
produced	NULL
by	NULL
the	NULL
xB-Mut	NULL
virus	NULL
suggests	NULL
that	NULL
enhancer-dependent	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
was	NULL
mainly	NULL
,	NULL
if	NULL
not	NULL
solely	NULL
,	NULL
affected	NULL
by	NULL
this	NULL
inhibitor	NULL
.	NULL

Furthermore	NULL
,	NULL
Z-LLL-H	NULL
treatment	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
a	NULL
housekeeping	NULL
gene	NULL
,	NULL
encoding	NULL
B-actin	NULL
,	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
in	NULL
our	NULL
experiments	NULL
.	NULL

This	NULL
compound	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
levels	NULL
of	NULL
the	NULL
Spl	NULL
protein	NULL
as	NULL
measured	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
;	NULL
the	NULL
levels	NULL
of	NULL
p53	NULL
protein	NULL
were	NULL
also	NULL
unaffected	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
these	NULL
observations	NULL
and	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
Z-LLL-H	NULL
impaired	NULL
specifically	NULL
enhancer-dependent	NULL
transcription	NULL
of	NULL
HIV-1	NULL
provirus	NULL
provides	NULL
further	NULL
support	NULL
for	NULL
our	NULL
hypothesis	NULL
that	NULL
permanent	NULL
enhancer	NULL
occupancy	NULL
is	NULL
needed	NULL
for	NULL
persistent	NULL
HIV-1	NULL
replication	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
We	NULL
originally	NULL
reported	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
occurs	NULL
upon	NULL
chronic	NULL
active	NULL
HIV-1	NULL
replication	NULL
in	NULL
the	NULL
U937	NULL
cell	NULL
line	NULL
,	NULL
a	NULL
monocytic	NULL
cell	NULL
system	NULL
which	NULL
expresses	NULL
very	NULL
little	NULL
,	NULL
if	NULL
any	NULL
,	NULL
nuclear	NULL
p50/p65	NULL
heterodimers	NULL
(	NULL
5	NULL
)	NULL
.	NULL

This	NULL
intriguing	NULL
phenomenon	NULL
has	NULL
since	NULL
been	NULL
confirmed	NULL
studies	NULL
of	NULL
both	NULL
U937	NULL
cells	NULL
(	NULL
47	NULL
)	NULL
and	NULL
monocyte-derived	NULL
normal	NULL
blood	NULL
macrophages	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
600	NULL
500	NULL
400	NULL
300	NULL
200	NULL
in	NULL
TNF-stimulated	NULL
cells	NULL
100	NULL
Percent	NULL
induction	NULL
of	NULL
HIV-1	NULL
total	NULL
RNA	NULL
TNF	NULL
=	NULL
+	NULL
=	NULL
+	NULL
HIV-WT	NULL
provirus	NULL
HIV-xB	NULL
Mut	NULL
provirus	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Analysis	NULL
of	NULL
wt	NULL
or	NULL
«	NULL
B-Mut	NULL
proviral	NULL
transcription	NULL
in	NULL
transiently	NULL
transfected	NULL
U937	NULL
cells	NULL
.	NULL

Twenty	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
half	NULL
of	NULL
the	NULL
cultures	NULL
were	NULL
treated	NULL
with	NULL
TNF	NULL
for	NULL
the	NULL
last	NULL
4	NULL
h	NULL
prior	NULL
to	NULL
harvesting	NULL
of	NULL
RNA	NULL
.	NULL

Total	NULL
RNA	NULL
from	NULL
10°	NULL
electroporated	NULL
cells	NULL
was	NULL
subjected	NULL
to	NULL
RT-PCR	NULL
analysis	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
HIV-1	NULL
and	NULL
B-actin	NULL
.	NULL

For	NULL
each	NULL
proviral	NULL
construct	NULL
,	NULL
corrected	NULL
densitometric	NULL
values	NULL
of	NULL
HIV-1	NULL
RNA	NULL
signals	NULL
in	NULL
TNF-stimulated	NULL
cells	NULL
were	NULL
expressed	NULL
as	NULL
percentages	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
total	NULL
HIV-1	NULL
RNA	NULL
into	NULL
unstimulated	NULL
control	NULL
cells	NULL
.	NULL

Corrected	NULL
densitometric	NULL
values	NULL
were	NULL
8,943	NULL
,	NULL
51,632	NULL
,	NULL
26,383	NULL
,	NULL
and	NULL
17,848	NULL
for	NULL
HIV	NULL
wt	NULL
,	NULL
HIV	NULL
wt	NULL
plus	NULL
TNF	NULL
,	NULL
HIV	NULL
«	NULL
B-Mut	NULL
,	NULL
and	NULL
HIV	NULL
«	NULL
B-Mut	NULL
plus	NULL
TNF	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
the	NULL
means	NULL
of	NULL
duplicate	NULL
samples	NULL
in	NULL
a	NULL
single	NULL
experiment	NULL
and	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
studies	NULL
.	NULL

2936	NULL
-	NULL
JACOUE	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
-	NULL
HIV-	NULL
«	NULL
B	NULL
Mut-	NULL
infected	NULL
cells	NULL
Z-LLL-H	NULL
(	NULL
uM	NULL
)	NULL
_0_	NULL
50	NULL
,	NULL
HIV	NULL
total	NULL
RNA	NULL
_	NULL
**	NULL
-_	NULL
|	NULL
®	NULL
ws	NULL
C	NULL
5g	NULL
100	NULL
Sl	NULL
t	NULL
9	NULL
9	NULL
9	NULL
80	NULL
23	NULL
b	NULL
s	NULL
6	NULL
E	NULL
5	NULL
fel	NULL
78	NULL
40	NULL
2	NULL
56	NULL
$	NULL
&	NULL
z	NULL
»	NULL
's	NULL
6	NULL
®	NULL
8	NULL
0	NULL
Z-LLL-H	NULL
(	NULL
uM	NULL
)	NULL
0	NULL
50	NULL
J.	NULL
ViroL	NULL
.	NULL

B	NULL
HIV-Wt-	NULL
infected	NULL
cells	NULL
0	NULL
20	NULL
10	NULL
50	NULL
__	NULL
C-	NULL
C+	NULL
M	NULL
220	NULL
<	NULL
upaae	NULL
``	NULL
|	NULL
mo	NULL
s	NULL
-154	NULL
w	NULL
|	NULL
=134	NULL
0	NULL
2	NULL
10	NULL
50	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

The	NULL
peptide	NULL
aldehyde	NULL
Z-LLL-H	NULL
inhibits	NULL
specifically	NULL
NF-	NULL
«	NULL
B-dependent	NULL
HIV-1-transcription	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
virus	NULL
derived	NULL
from	NULL
proviral	NULL
DNA-transfected	NULL
Cos-7	NULL
cells	NULL
.	NULL

«	NULL
B-Mut-	NULL
and	NULL
wt-infected	NULL
U937	NULL
cells	NULL
(	NULL
26	NULL
days	NULL
after	NULL
infection	NULL
)	NULL
were	NULL
treated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
inhibitor	NULL
Z-LLL-H.	NULL
(	NULL
A	NULL
)	NULL
RNA	NULL
(	NULL
10°	NULL
cell	NULL
equivalents	NULL
)	NULL
extracted	NULL
from	NULL
these	NULL
cells	NULL
was	NULL
subjected	NULL
to	NULL
primer	NULL
extension	NULL
and	NULL
subsequent	NULL
PCR	NULL
with	NULL
B-actin-specific	NULL
primers	NULL
as	NULL
described	NULL
above	NULL
.	NULL

RT-PCR	NULL
products	NULL
of	NULL
B-actin	NULL
were	NULL
used	NULL
to	NULL
normalized	NULL
the	NULL
amount	NULL
of	NULL
HIV-1	NULL
cDNA	NULL
.	NULL

Nested	NULL
PCR	NULL
was	NULL
performed	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
HIV-1	NULL
RNAs	NULL
.	NULL

PCRs	NULL
with	NULL
uninfected	NULL
cells	NULL
and	NULL
HIV-11	NULL
wj-infected	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cell	NULL
equivalents	NULL
)	NULL
served	NULL
as	NULL
negative	NULL
(	NULL
C-	NULL
)	NULL
and	NULL
positive	NULL
(	NULL
C+	NULL
)	NULL
controls	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
B	NULL
)	NULL
For	NULL
each	NULL
set	NULL
of	NULL
infected	NULL
cells	NULL
,	NULL
total	NULL
HIV-1	NULL
RNA	NULL
densitometric	NULL
values	NULL
were	NULL
expressed	NULL
as	NULL
percentages	NULL
of	NULL
the	NULL
residual	NULL
HIV-1	NULL
transcription	NULL
in	NULL
untreated	NULL
cells	NULL
.	NULL

These	NULL
percentages	NULL
were	NULL
plotted	NULL
against	NULL
the	NULL
various	NULL
concentrations	NULL
of	NULL
the	NULL
inhibitor	NULL
Z-LLL-H.	NULL
activities	NULL
of	NULL
HIV-1	NULL
enhancer-driven	NULL
expression	NULL
vectors	NULL
,	NULL
transiently	NULL
transfected	NULL
into	NULL
chronically	NULL
infected	NULL
U937	NULL
cells	NULL
,	NULL
were	NULL
found	NULL
to	NULL
be	NULL
constitutively	NULL
increased	NULL
as	NULL
a	NULL
result	NULL
of	NULL
chronic	NULL
infection	NULL
,	NULL
it	NULL
was	NULL
possible	NULL
to	NULL
postulate	NULL
a	NULL
role	NULL
for	NULL
NF-kB	NULL
activation	NULL
in	NULL
the	NULL
indefinite	NULL
viral	NULL
transcription	NULL
and	NULL
replication	NULL
observed	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
.	NULL

Alternatively	NULL
,	NULL
however	NULL
,	NULL
it	NULL
could	NULL
be	NULL
reasoned	NULL
that	NULL
HIV	NULL
Tat	NULL
protein	NULL
,	NULL
produced	NULL
in	NULL
a	NULL
functional	NULL
way	NULL
in	NULL
chronically	NULL
HIV-1	NULL
;	NULL
U937	NULL
cells	NULL
,	NULL
is	NULL
sufficient	NULL
to	NULL
perpetuate	NULL
transcription	NULL
of	NULL
the	NULL
integrated	NULL
provirus	NULL
,	NULL
which	NULL
would	NULL
be	NULL
merely	NULL
initiated	NULL
by	NULL
NF-kB	NULL
.	NULL

Indeed	NULL
,	NULL
addition	NULL
of	NULL
exogenous	NULL
HIV	NULL
Tat	NULL
protein	NULL
to	NULL
U1	NULL
cells	NULL
,	NULL
a	NULL
latently	NULL
infected	NULL
sub-clone	NULL
of	NULL
U937	NULL
cells	NULL
,	NULL
induces	NULL
HIV-1	NULL
replication	NULL
(	NULL
1	NULL
,	NULL
11	NULL
,	NULL
17	NULL
)	NULL
.	NULL

In	NULL
transient	NULL
transfection	NULL
assays	NULL
,	NULL
HIV	NULL
Tat	NULL
expression	NULL
transacti-vates	NULL
LTR-driven	NULL
vectors	NULL
independently	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
elements	NULL
.	NULL

However	NULL
,	NULL
numerous	NULL
reports	NULL
suggested	NULL
that	NULL
Tat	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
its	NULL
capacity	NULL
to	NULL
elongate	NULL
viral	NULL
RNA	NULL
through	NULL
an	NULL
interaction	NULL
with	NULL
the	NULL
Tat-responsive	NULL
element	NULL
sequence	NULL
,	NULL
must	NULL
somehow	NULL
interact	NULL
with	NULL
multiprotein	NULL
complexes	NULL
associated	NULL
with	NULL
the	NULL
HIV	NULL
enhancer	NULL
region	NULL
and	NULL
the	NULL
primary	NULL
initiation	NULL
domain	NULL
to	NULL
exert	NULL
its	NULL
full	NULL
transactivating	NULL
effects	NULL
on	NULL
the	NULL
viral	NULL
LTR	NULL
(	NULL
9	NULL
,	NULL
28	NULL
,	NULL
36	NULL
,	NULL
37	NULL
,	NULL
48	NULL
,	NULL
61	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
recent	NULL
work	NULL
from	NULL
our	NULL
laboratory	NULL
shows	NULL
that	NULL
NF-	NULL
«	NULL
B-independent	NULL
HIV	NULL
Tat	NULL
transactivation	NULL
occurs	NULL
in	NULL
transformed	NULL
lymphoblastoid	NULL
T-cell	NULL
lines	NULL
but	NULL
not	NULL
in	NULL
resting	NULL
CD4	NULL
T	NULL
lymphocytes	NULL
purified	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
(	NULL
2	NULL
)	NULL
.	NULL

These	NULL
notions	NULL
prompted	NULL
us	NULL
to	NULL
revisit	NULL
the	NULL
role	NULL
of	NULL
NF-kB	NULL
activation	NULL
in	NULL
the	NULL
long-term	NULL
control	NULL
of	NULL
HIV-1	NULL
provirus	NULL
transcription	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocytic	NULL
lineage	NULL
.	NULL

In	NULL
the	NULL
U1	NULL
cell	NULL
system	NULL
,	NULL
it	NULL
is	NULL
well	NULL
known	NULL
that	NULL
TNF	NULL
stimulation	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
increases	NULL
the	NULL
very	NULL
low	NULL
transcription	NULL
levels	NULL
of	NULL
the	NULL
two	NULL
integrated	NULL
provirus	NULL
copies	NULL
observed	NULL
in	NULL
unstimulated	NULL
cells	NULL
(	NULL
18	NULL
,	NULL
24	NULL
,	NULL
50	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Phorbol	NULL
myristate	NULL
acetate	NULL
stimulation	NULL
of	NULL
U1	NULL
cells	NULL
,	NULL
acting	NULL
through	NULL
an	NULL
autocrine	NULL
secretion	NULL
of	NULL
TNF	NULL
,	NULL
results	NULL
in	NULL
a	NULL
clear	NULL
increase	NULL
in	NULL
dimeth-ylsulfate	NULL
sensitivity	NULL
of	NULL
a	NULL
guanine	NULL
in	NULL
the	NULL
downstream	NULL
enhancer	NULL
repeat	NULL
in	NULL
LTR	NULL
footprinting	NULL
experiments	NULL
that	NULL
likely	NULL
is	NULL
due	NULL
to	NULL
the	NULL
occupancy	NULL
of	NULL
the	NULL
enhancer	NULL
region	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
a	NULL
correlation	NULL
between	NULL
nuclear	NULL
NF-	NULL
«	NULL
xB-binding	NULL
activity	NULL
and	NULL
increased	NULL
transcription	NULL
was	NULL
reported	NULL
(	NULL
15	NULL
,	NULL
51	NULL
)	NULL
.	NULL

From	NULL
these	NULL
experiments	NULL
,	NULL
however	NULL
,	NULL
it	NULL
can	NULL
not	NULL
be	NULL
excluded	NULL
that	NULL
TNF	NULL
or	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
induces	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
NF-kB	NULL
,	NULL
other	NULL
molecular	NULL
events	NULL
which	NULL
can	NULL
participate	NULL
in	NULL
the	NULL
control	NULL
of	NULL
HIV-1	NULL
genome	NULL
transcription	NULL
.	NULL

We	NULL
have	NULL
therefore	NULL
used	NULL
a	NULL
method	NULL
which	NULL
allows	NULL
specific	NULL
termination	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
function	NULL
.	NULL

We	NULL
recently	NULL
reported	NULL
(	NULL
3	NULL
)	NULL
that	NULL
TNF	NULL
stimulation	NULL
,	NULL
when	NULL
used	NULL
as	NULL
a	NULL
transient	NULL
pulse	NULL
followed	NULL
by	NULL
washing	NULL
of	NULL
cells	NULL
,	NULL
first	NULL
induces	NULL
a	NULL
nuclear	NULL
translocation	NULL
of	NULL
p50/p65	NULL
NF-	NULL
«	NULL
B	NULL
heterodimers	NULL
and	NULL
,	NULL
through	NULL
the	NULL
lat-ter	NULL
,	NULL
the	NULL
rapid	NULL
de	NULL
novo	NULL
NF-	NULL
«	NULL
xB-dependent	NULL
activation	NULL
of	NULL
IxBa	NULL
gene	NULL
transcription	NULL
.	NULL

Newly	NULL
transcribed	NULL
IxBa	NULL
protein	NULL
translo-cates	NULL
into	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
binds	NULL
to	NULL
NF-kB	NULL
heterodimers	NULL
and	NULL
terminates	NULL
their	NULL
function	NULL
in	NULL
a	NULL
highly	NULL
specific	NULL
manner	NULL
(	NULL
3	NULL
)	NULL
.	NULL

This	NULL
does	NULL
not	NULL
happens	NULL
if	NULL
TNF	NULL
is	NULL
maintained	NULL
in	NULL
the	NULL
culture	NULL
medium	NULL
,	NULL
since	NULL
permanent	NULL
degradation	NULL
of	NULL
IxBa	NULL
,	NULL
including	NULL
the	NULL
newly	NULL
synthesized	NULL
molecules	NULL
,	NULL
occurs	NULL
.	NULL

Using	NULL
this	NULL
approach	NULL
,	NULL
we	NULL
have	NULL
now	NULL
compared	NULL
the	NULL
effects	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
and	NULL
endogenous	NULL
HIV-1	NULL
provirus	NULL
transcription	NULL
of	NULL
prolonged	NULL
(	NULL
8-h	NULL
)	NULL
or	NULL
pulsed	NULL
(	NULL
for	NULL
2	NULL
h	NULL
,	NULL
followed	NULL
by	NULL
6	NULL
h	NULL
in	NULL
normal	NULL
culture	NULL
medium	NULL
)	NULL
stimulation	NULL
of	NULL
U1	NULL
cells	NULL
with	NULL
recombinant	NULL
TNF	NULL
.	NULL

Whereas	NULL
continuous	NULL
TNF	NULL
stimulation	NULL
induced	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
a	NULL
steady	NULL
increase	NULL
in	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
and	NULL
HIV-1	NULL
transcription	NULL
,	NULL
a	NULL
2-h	NULL
TNF	NULL
pulse	NULL
resulted	NULL
in	NULL
early	NULL
activation	NULL
of	NULL
both	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
and	NULL
viral	NULL
transcription	NULL
,	NULL
followed	NULL
after	NULL
a	NULL
6-h	NULL
chase	NULL
by	NULL
the	NULL
disappearance	NULL
of	NULL
nuclear	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
.	NULL

This	NULL
phenomenon	NULL
was	NULL
accompanied	NULL
by	NULL
a	NULL
brisk	NULL
decrease	NULL
of	NULL
viral	NULL
transcription	NULL
to	NULL
levels	NULL
similar	NULL
to	NULL
those	NULL
observed	NULL
in	NULL
2-h	NULL
TNF-stimulated	NULL
U1	NULL
cells	NULL
.	NULL

This	NULL
result	NULL
indicated	NULL
that	NULL
TNF-induced	NULL
early	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
to	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
is	NULL
sufficient	NULL
to	NULL
launch	NULL
HIV	NULL
genome	NULL
transcription	NULL
but	NULL
is	NULL
,	NULL
in	NULL
addition	NULL
,	NULL
needed	NULL
for	NULL
persistent	NULL
transcription	NULL
.	NULL

This	NULL
finding	NULL
provided	NULL
a	NULL
first	NULL
indication	NULL
that	NULL
ongoing	NULL
transcription	NULL
of	NULL
integrated	NULL
HIV-1	NULL
provirus	NULL
depends	NULL
strictly	NULL
on	NULL
actual	NULL
occupancy	NULL
of	NULL
enhancer	NULL
motifs	NULL
by	NULL
NF-kB	NULL
heterodimers	NULL
.	NULL

This	NULL
interpretation	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
results	NULL
of	NULL
superinfection	NULL
experiments	NULL
(	NULL
12	NULL
)	NULL
and	NULL
in	NULL
keeping	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
HIV-induced	NULL
NF-kB	NULL
activity	NULL
may	NULL
be	NULL
one	NULL
mechanism	NULL
which	NULL
restricts	NULL
viral	NULL
replication	NULL
in	NULL
U1	NULL
cells	NULL
(	NULL
12	NULL
,	NULL
52	NULL
)	NULL
.	NULL

Whereas	NULL
the	NULL
U1	NULL
cell	NULL
system	NULL
allowed	NULL
us	NULL
to	NULL
test	NULL
the	NULL
role	NULL
of	NULL
p50/p65	NULL
heterodimers	NULL
in	NULL
early	NULL
steps	NULL
of	NULL
HIV-1	NULL
reactivation	NULL
,	NULL
the	NULL
chronically	NULL
HIV-infected	NULL
U937	NULL
cell	NULL
model	NULL
offered	NULL
the	NULL
opportunity	NULL
to	NULL
test	NULL
the	NULL
role	NULL
of	NULL
enhancer	NULL
occupancy	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
het-	NULL
voL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
erodimers	NULL
in	NULL
the	NULL
intense	NULL
transcriptional	NULL
activity	NULL
of	NULL
integrated	NULL
HIV-1	NULL
provirus	NULL
in	NULL
a	NULL
fully	NULL
permissive	NULL
cell	NULL
environment	NULL
producing	NULL
Tat	NULL
protein	NULL
on	NULL
a	NULL
permanent	NULL
basis	NULL
.	NULL

Partial	NULL
blockade	NULL
of	NULL
this	NULL
permanent	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
induced	NULL
by	NULL
viral	NULL
replication	NULL
itself	NULL
in	NULL
this	NULL
model	NULL
system	NULL
was	NULL
obtained	NULL
by	NULL
inhibition	NULL
of	NULL
the	NULL
proteolytic	NULL
activity	NULL
of	NULL
the	NULL
proteasome	NULL
.	NULL

As	NULL
early	NULL
as	NULL
2	NULL
h	NULL
after	NULL
addition	NULL
of	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
Z-LLL-H	NULL
,	NULL
a	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
both	NULL
nuclear	NULL
binding	NULL
activity	NULL
and	NULL
endogenous	NULL
HIV	NULL
transcription	NULL
was	NULL
observed	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
a	NULL
clear	NULL
indication	NULL
that	NULL
viral	NULL
replication	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
U937	NULL
cells	NULL
through	NULL
a	NULL
proteasome-dependent	NULL
pathway	NULL
and	NULL
that	NULL
the	NULL
HIV-induced	NULL
,	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
observed	NULL
in	NULL
the	NULL
U937	NULL
cell	NULL
line	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
perpetuating	NULL
HIV-1	NULL
genome	NULL
transcription	NULL
.	NULL

It	NULL
should	NULL
be	NULL
stressed	NULL
that	NULL
no	NULL
significant	NULL
cell	NULL
toxicity	NULL
was	NULL
induced	NULL
by	NULL
a	NULL
2-h	NULL
Z-LLL-H	NULL
treatment	NULL
of	NULL
U937	NULL
cells	NULL
,	NULL
whether	NULL
infected	NULL
or	NULL
not	NULL
,	NULL
and	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
Sp1	NULL
and	NULL
p53	NULL
proteins	NULL
were	NULL
not	NULL
modified	NULL
by	NULL
such	NULL
treatment	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Eliminating	NULL
a	NULL
role	NULL
for	NULL
p53	NULL
modifications	NULL
in	NULL
Z-LLL-H-treated	NULL
cells	NULL
was	NULL
indeed	NULL
important	NULL
,	NULL
since	NULL
this	NULL
molecule	NULL
is	NULL
also	NULL
degraded	NULL
in	NULL
a	NULL
ubiquitin	NULL
proteasome-dependent	NULL
manner	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
human	NULL
papillomavirus	NULL
type	NULL
16	NULL
(	NULL
42	NULL
)	NULL
.	NULL

The	NULL
respective	NULL
roles	NULL
of	NULL
NF-kB	NULL
and	NULL
HIV-Tat	NULL
in	NULL
HIV-1	NULL
transcription	NULL
in	NULL
chronically	NULL
infected	NULL
U937	NULL
cells	NULL
are	NULL
not	NULL
entirely	NULL
understood	NULL
.	NULL

TNF	NULL
stimulation	NULL
of	NULL
U937	NULL
cells	NULL
was	NULL
shown	NULL
to	NULL
induce	NULL
the	NULL
replication	NULL
of	NULL
Tat-defective	NULL
virus	NULL
to	NULL
near	NULL
wt	NULL
levels	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
and	NULL
also	NULL
to	NULL
overcome	NULL
the	NULL
block	NULL
of	NULL
wt	NULL
HIV	NULL
replication	NULL
induced	NULL
by	NULL
an	NULL
inhibitor	NULL
of	NULL
Tat	NULL
(	NULL
37	NULL
)	NULL
.	NULL

We	NULL
reported	NULL
earlier	NULL
that	NULL
the	NULL
activities	NULL
of	NULL
LTR-driven	NULL
expression	NULL
vectors	NULL
deleted	NULL
of	NULL
NF-kB	NULL
sequences	NULL
and	NULL
transiently	NULL
transfected	NULL
into	NULL
chronically	NULL
infected	NULL
U937	NULL
cells	NULL
are	NULL
diminished	NULL
20-to	NULL
30-fold	NULL
but	NULL
are	NULL
not	NULL
abolished	NULL
.	NULL

It	NULL
is	NULL
thus	NULL
likely	NULL
that	NULL
NF-kB	NULL
and	NULL
Tat	NULL
,	NULL
bound	NULL
to	NULL
their	NULL
respective	NULL
DNA	NULL
response	NULL
elements	NULL
on	NULL
the	NULL
LTR	NULL
and	NULL
the	NULL
nascent	NULL
transcripts	NULL
of	NULL
the	NULL
integrated	NULL
HIV	NULL
provirus	NULL
,	NULL
collaborate	NULL
as	NULL
part	NULL
of	NULL
a	NULL
large	NULL
transcriptional	NULL
protein	NULL
complex	NULL
to	NULL
maintain	NULL
the	NULL
high-level	NULL
viral	NULL
expression	NULL
observed	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Our	NULL
present	NULL
work	NULL
suggests	NULL
that	NULL
NF-kB	NULL
heterodimers	NULL
represent	NULL
a	NULL
keystone	NULL
in	NULL
the	NULL
building	NULL
of	NULL
such	NULL
a	NULL
multiprotein	NULL
complex	NULL
.	NULL

Our	NULL
final	NULL
evidence	NULL
for	NULL
the	NULL
critical	NULL
role	NULL
of	NULL
NF-kB	NULL
in	NULL
maintaining	NULL
HIV-1	NULL
transcriptional	NULL
activity	NULL
was	NULL
sought	NULL
by	NULL
infecting	NULL
U937	NULL
cells	NULL
with	NULL
an	NULL
HIV	NULL
provirus	NULL
carrying	NULL
specific	NULL
mutations	NULL
in	NULL
the	NULL
3	NULL
'	NULL
and	NULL
5	NULL
'	NULL
LTRs	NULL
which	NULL
abolish	NULL
response	NULL
to	NULL
TNF	NULL
and	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
.	NULL

The	NULL
profound	NULL
transcriptional	NULL
defect	NULL
shown	NULL
by	NULL
this	NULL
construct	NULL
confirmed	NULL
that	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
must	NULL
bind	NULL
NF-kB	NULL
heterodimers	NULL
for	NULL
active	NULL
viral	NULL
replication	NULL
to	NULL
occur	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Inhibition	NULL
of	NULL
proteasome	NULL
activity	NULL
suppressed	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
wt	NULL
provirus	NULL
but	NULL
not	NULL
that	NULL
of	NULL
its	NULL
mutated	NULL
counterpart	NULL
,	NULL
providing	NULL
further	NULL
evidence	NULL
for	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
inhibitor	NULL
used	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
report	NULL
showing	NULL
that	NULL
a	NULL
kB-defective	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
construct	NULL
is	NULL
unable	NULL
to	NULL
replicate	NULL
in	NULL
primary	NULL
macrophages	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
strategy	NULL
of	NULL
self-perpetuation	NULL
of	NULL
proviral	NULL
genome	NULL
transcription	NULL
through	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
appears	NULL
to	NULL
be	NULL
used	NULL
by	NULL
HIV-1	NULL
in	NULL
the	NULL
monocytic	NULL
lineage	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
HIV-1	NULL
to	NULL
induce	NULL
permissiveness	NULL
to	NULL
its	NULL
own	NULL
replication	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocytic	NULL
lineage	NULL
may	NULL
underlie	NULL
the	NULL
indefinite	NULL
and	NULL
intense	NULL
production	NULL
of	NULL
viral	NULL
particles	NULL
observed	NULL
in	NULL
infected	NULL
patients	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
J.	NULL
Alcami	NULL
for	NULL
helpful	NULL
technical	NULL
suggestions	NULL
and	NULL
S.	NULL
Michelson	NULL
for	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
thank	NULL
C.	NULL
Goupil	NULL
for	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

J.-M.J.	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
fellowship	NULL
from	NULL
the	NULL
Agence	NULL
Nationale	NULL
de	NULL
Recherche	NULL
sur	NULL
le	NULL
SIDA	NULL
.	NULL

B.F.	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Spanish	NULL
Ministry	NULL
of	NULL
Science	NULL
and	NULL
Education	NULL
(	NULL
EX93	NULL
02854375	NULL
)	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
PERSISTENT	NULL
REPLICATION	NULL
OF	NULL
HIV-1	NULL
IN	NULL
MONOCYTES	NULL
REQUIRES	NULL
NF-	NULL
«	NULL
B	NULL
2937	NULL
the	NULL
Agence	NULL
Nationale	NULL
de	NULL
Recherche	NULL
sur	NULL
le	NULL
SIDA	NULL
and	NULL
an	NULL
European	NULL
Community	NULL
Concerted	NULL
Action	NULL
(	NULL
Project	NULL
ROCIO	NULL
)	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Adams	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
Sharmeen	NULL
,	NULL
J.	NULL
Kimpton	NULL
,	NULL
J.	NULL
M.	NULL
Romeo	NULL
,	NULL
J.	NULL
V.	NULL
Garcia	NULL
,	NULL
B.	NULL
M.	NULL
Peterlin	NULL
,	NULL
M.	NULL
Groudine	NULL
,	NULL
and	NULL
M.	NULL
Emerman	NULL
.	NULL

1994	NULL
.	NULL

Cellular	NULL
latency	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus-infected	NULL
individuals	NULL
with	NULL
high	NULL
CD4	NULL
levels	NULL
can	NULL
be	NULL
detected	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
promoter-proximal	NULL
transcripts	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:3862-3866	NULL
.	NULL

2	NULL
.	NULL

Alcami	NULL
,	NULL
J.	NULL
,	NULL
T.	NULL
Lain	NULL
De	NULL
Lera	NULL
,	NULL
L.	NULL
Folgueira	NULL
,	NULL
M.	NULL
A.	NULL
Pedraza	NULL
,	NULL
J.	NULL
M.	NULL
Jacqué	NULL
,	NULL
F.	NULL
Bachelerie	NULL
,	NULL
A.	NULL
R.	NULL
Noriega	NULL
,	NULL
R.	NULL
T.	NULL
Hay	NULL
,	NULL
D.	NULL
Harrich	NULL
,	NULL
R.	NULL
B.	NULL
Gaynor	NULL
,	NULL
J.-L.	NULL
Virelizier	NULL
,	NULL
and	NULL
F.	NULL
Arenzana-Seisdedos	NULL
.	NULL

1995	NULL
.	NULL

Absolute	NULL
dependence	NULL
on	NULL
B	NULL
responsive	NULL
elements	NULL
for	NULL
initiation	NULL
and	NULL
Tat-mediated	NULL
amplification	NULL
of	NULL
HIV	NULL
transcription	NULL
in	NULL
blood	NULL
CD4	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:1552-1560	NULL
.	NULL

3	NULL
.	NULL

Arenzana-Seisdedos	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
Thompson	NULL
,	NULL
M.	NULL
Rodriguez	NULL
,	NULL
F.	NULL
Bachelerie	NULL
,	NULL
D.	NULL
Thomas	NULL
,	NULL
and	NULL
R.	NULL
Hay	NULL
.	NULL

1995	NULL
.	NULL

Inducible	NULL
nuclear	NULL
expression	NULL
of	NULL
newly	NULL
synthesized	NULL
IxBo	NULL
negatively	NULL
regulates	NULL
DNA-binding	NULL
and	NULL
transcriptional	NULL
activities	NULL
of	NULL
NF-kB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2689-2696	NULL
.	NULL

4	NULL
.	NULL

Arrigo	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
R.	NULL
Weitsman	NULL
,	NULL
J.	NULL
D.	NULL
Rosenblatt	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
.	NULL

1989	NULL
.	NULL

Analysis	NULL
of	NULL
rev	NULL
function	NULL
on	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
replication	NULL
in	NULL
lymphoid	NULL
cells	NULL
by	NULL
using	NULL
a	NULL
quantitative	NULL
polymerase	NULL
chain	NULL
reaction	NULL
method	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:4875-4881	NULL
.	NULL

5	NULL
.	NULL

Bachelerie	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
and	NULL
J.-L.	NULL
Virelizier	NULL
.	NULL

1991	NULL
.	NULL

HIV	NULL
enhancer	NULL
activity	NULL
perpetuated	NULL
by	NULL
NF-kappa	NULL
B	NULL
induction	NULL
on	NULL
infection	NULL
of	NULL
monocytes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
350:709-712	NULL
.	NULL

6	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
DNA-binding	NULL
activity	NULL
in	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
precursor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
53:211-217	NULL
.	NULL

7	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
T.	NULL
S.	NULL
Finco	NULL
,	NULL
P.	NULL
V.	NULL
Nantermet	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
lead	NULL
to	NULL
phosphorylation	NULL
and	NULL
loss	NULL
of	NULL
IxBa	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3301-3310	NULL
.	NULL

8	NULL
.	NULL

Bellas	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
N.	NULL
Hopkins	NULL
,	NULL
and	NULL
Y.	NULL
Li	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
is	NULL
necessary	NULL
for	NULL
efficient	NULL
replication	NULL
of	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
of	NULL
ma-caques	NULL
in	NULL
primary	NULL
macrophages	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:2908-2913	NULL
.	NULL

9	NULL
.	NULL

Berkhout	NULL
,	NULL
B.	NULL
,	NULL
A.	NULL
Gatignol	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
,	NULL
and	NULL
K.	NULL
T.	NULL
Jeang	NULL
.	NULL

1990	NULL
.	NULL

TAR-independent	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
:	NULL
evidence	NULL
that	NULL
tat	NULL
requires	NULL
specific	NULL
regions	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

Cell	NULL
62:757-767	NULL
.	NULL

10	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1993	NULL
.	NULL

Mutual	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
IxBa	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2532-2536	NULL
.	NULL

11	NULL
.	NULL

Cannon	NULL
,	NULL
P.	NULL
,	NULL
S.-H.	NULL
Kim	NULL
,	NULL
C.	NULL
Ulich	NULL
,	NULL
and	NULL
S.	NULL
Kim	NULL
.	NULL

1994	NULL
.	NULL

Analysis	NULL
of	NULL
Tat	NULL
function	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1-infected	NULL
low-level-expression	NULL
cell	NULL
lines	NULL
U1	NULL
and	NULL
ACH2	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:1993-1997	NULL
.	NULL

12	NULL
.	NULL

Chen	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
K.	NULL
Saksela	NULL
,	NULL
R.	NULL
Andino	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1994	NULL
.	NULL

Distinct	NULL
modes	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
proviral	NULL
latency	NULL
revealed	NULL
by	NULL
superinfection	NULL
of	NULL
nonproductively	NULL
infected	NULL
cell	NULL
lines	NULL
with	NULL
recombinant	NULL
luciferase-encoding	NULL
viruses	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:654-660	NULL
.	NULL

13	NULL
.	NULL

Chen	NULL
,	NULL
Z.	NULL
,	NULL
J.	NULL
Haegler	NULL
,	NULL
V.	NULL
J.	NULL
Palombella	NULL
,	NULL
F.	NULL
Melandri	NULL
,	NULL
D.	NULL
Scherer	NULL
,	NULL
D.	NULL
Ballard	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1995	NULL
.	NULL

Signal-induced	NULL
site-specific	NULL
phosphorylation	NULL
targets	NULL
IxBa	NULL
to	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:1586-1597	NULL
.	NULL

14	NULL
.	NULL

Chiao	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
S.	NULL
Miyamoto	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1994	NULL
.	NULL

Autoregulation	NULL
of	NULL
IxBa	NULL
activity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:28-32	NULL
.	NULL

15	NULL
.	NULL

Demarchi	NULL
,	NULL
F.	NULL
,	NULL
P.	NULL
D'Agaro	NULL
,	NULL
A.	NULL
Falaschi	NULL
,	NULL
and	NULL
M.	NULL
Giacca	NULL
.	NULL

1993	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
analysis	NULL
of	NULL
constitutive	NULL
and	NULL
inducible	NULL
protein-DNA	NULL
interactions	NULL
at	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:7450-7460	NULL
.	NULL

16	NULL
.	NULL

Du	NULL
,	NULL
W.	NULL
,	NULL
D.	NULL
Thanos	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1993	NULL
.	NULL

Mechanisms	NULL
of	NULL
transcriptional	NULL
synergism	NULL
between	NULL
distinct	NULL
virus-inducible	NULL
enhancer	NULL
elements	NULL
.	NULL

Cell	NULL
74:887-898	NULL
.	NULL

17	NULL
.	NULL

Duan	NULL
,	NULL
L.	NULL
,	NULL
J.	NULL
W.	NULL
Oakes	NULL
,	NULL
A.	NULL
Ferraro	NULL
,	NULL
O.	NULL
Bagasra	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Pomerantz	NULL
.	NULL

1994	NULL
.	NULL

Tat	NULL
and	NULL
Rev	NULL
differentially	NULL
affect	NULL
restricted	NULL
replication	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
in	NULL
various	NULL
cells	NULL
.	NULL

Virology	NULL
199:474-478	NULL
.	NULL

18	NULL
.	NULL

Folks	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
K.	NULL
A.	NULL
Clouse	NULL
,	NULL
J.	NULL
Justement	NULL
,	NULL
A.	NULL
Rabson	NULL
,	NULL
E.	NULL
Dubh	NULL
,	NULL
J.	NULL
H.	NULL
Kerhl	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
induces	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
a	NULL
chronically	NULL
infected	NULL
T-cell	NULL
clone	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2365-2368	NULL
.	NULL

19	NULL
.	NULL

Folks	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
J.	NULL
Justement	NULL
,	NULL
A.	NULL
Kinter	NULL
,	NULL
C.	NULL
A.	NULL
Dinarello	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1987	NULL
.	NULL

Cytokine	NULL
induced	NULL
expression	NULL
of	NULL
HIV-1	NULL
in	NULL
a	NULL
chronically	NULL
infected	NULL
promonocytic	NULL
cell	NULL
line	NULL
.	NULL

Science	NULL
238:800-802	NULL
.	NULL

20	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1992	NULL
.	NULL

Independent	NULL
modes	NULL
of	NULL
transcriptional	NULL
activation	NULL
by	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:775-782	NULL
.	NULL

21	NULL
.	NULL

Gaynor	NULL
,	NULL
R.	NULL
1992	NULL
.	NULL

Cellular	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
.	NULL

AIDS	NULL
6:347-363	NULL
.	NULL

22	NULL
.	NULL

Gendelman	NULL
,	NULL
H.	NULL
E.	NULL
,	NULL
and	NULL
P.	NULL
S.	NULL
Morahan	NULL
.	NULL

1992	NULL
.	NULL

Macrophages	NULL
in	NULL
viral	NULL
infection	NULL
in	NULL
the	NULL
macrophage	NULL
,	NULL
p.	NULL
189-191	NULL
.	NULL

Oxford	NULL
University	NULL
Press	NULL
,	NULL
Oxford	NULL
.	NULL

23	NULL
.	NULL

Greenberg	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
and	NULL
E.	NULL
B.	NULL
Ziff	NULL
.	NULL

1984	NULL
.	NULL

Stimulation	NULL
of	NULL
3T3	NULL
cells	NULL
induces	NULL
transcription	NULL
of	NULL
the	NULL
c-fos	NULL
proto-oncogene	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
311:433-438	NULL
.	NULL

24	NULL
.	NULL

Griffin	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
T.	NULL
Folks	NULL
,	NULL
S.	NULL
Kunkels	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
during	NULL
monocyte	NULL
differentiation	NULL
by	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
339:70-73	NULL
.	NULL

2938	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

JACQOUE	NULL
ET	NULL
AL	NULL
.	NULL

Grilli	NULL
,	NULL
M.	NULL
,	NULL
J.-J	NULL
.	NULL

Chiu	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1993	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
and	NULL
rel	NULL
:	NULL
participants	NULL
in	NULL
a	NULL
multiform	NULL
transcriptional	NULL
regulatory	NULL
system	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

143:1-62	NULL
.	NULL

Gualberto	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
L.	NULL
Hixon	NULL
,	NULL
T.	NULL
S.	NULL
Finco	NULL
,	NULL
N.	NULL
D.	NULL
Perkins	NULL
,	NULL
G.	NULL
J.	NULL
Nabel	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1995	NULL
.	NULL

A	NULL
proliferative	NULL
p53-responsive	NULL
element	NULL
mediates	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:3450-3459	NULL
.	NULL

Hamoui	NULL
,	NULL
S.	NULL
,	NULL
J.-P.	NULL
Benedetto	NULL
,	NULL
M.	NULL
Garret	NULL
,	NULL
and	NULL
J.	NULL
Bonnet	NULL
.	NULL

1994	NULL
.	NULL

Quantitation	NULL
of	NULL
mRNA	NULL
species	NULL
by	NULL
RT-PCR	NULL
on	NULL
total	NULL
mRNA	NULL
population	NULL
.	NULL

PCR	NULL
Methods	NULL
Appl	NULL
.	NULL

4:160-166	NULL
.	NULL

Harrich	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Garcia	NULL
,	NULL
R.	NULL
Mitsuyasu	NULL
,	NULL
and	NULL
R.	NULL
Gaynor	NULL
.	NULL

1990	NULL
.	NULL

TAR	NULL
independent	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
phorbol	NULL
ester	NULL
stimulated	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:4417-4423	NULL
.	NULL

Haskill	NULL
S.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Beg	NULL
,	NULL
S.	NULL
M.	NULL
Tompkins	NULL
,	NULL
J.	NULL
S.	NULL
Morris	NULL
,	NULL
A.	NULL
D.	NULL
Yurochko	NULL
,	NULL
A.	NULL
Sampson-Johannes	NULL
,	NULL
K.	NULL
Mondal	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IxB-like	NULL
activity	NULL
.	NULL

Cell	NULL
65:1281-1289	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
I.	NULL
Alkalay	NULL
,	NULL
M.	NULL
Kronke	NULL
,	NULL
Y.	NULL
Ben-Neriah	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1993	NULL
.	NULL

Rapid	NULL
proteolysis	NULL
of	NULL
IxBa	NULL
«	NULL
is	NULL
necessary	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
365:182-185	NULL
.	NULL

Ho	NULL
,	NULL
D.	NULL
,	NULL
A.	NULL
Neuman	NULL
,	NULL
A.	NULL
S.	NULL
Perelson	NULL
,	NULL
W.	NULL
Chen	NULL
,	NULL
J.	NULL
M.	NULL
Leonard	NULL
,	NULL
and	NULL
M.	NULL
Markowitz	NULL
.	NULL

1995	NULL
.	NULL

Rapid	NULL
turnover	NULL
of	NULL
plasma	NULL
virions	NULL
and	NULL
CD4	NULL
lymphocytes	NULL
in	NULL
HIV-1	NULL
infection	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
373:123-126	NULL
.	NULL

Ho	NULL
,	NULL
W.-Z	NULL
.	NULL

,	NULL
R.	NULL
Cherukuri	NULL
,	NULL
and	NULL
S.	NULL
D.	NULL
Douglas	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
macrophage	NULL
and	NULL
HIV-1	NULL
,	NULL
p.	NULL
569-588	NULL
.	NULL

In	NULL
B.	NULL
S.	NULL
Zwilling	NULL
and	NULL
T.	NULL
K.	NULL
Eisenstein	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Macroph-ages-pathogen	NULL
interactions	NULL
.	NULL

Marcel	NULL
Dekker	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
D.	NULL
Kerr	NULL
,	NULL
A.	NULL
Kakizuka	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
1992	NULL
.	NULL

I	NULL
«	NULL
By	NULL
,	NULL
a	NULL
70	NULL
kd	NULL
protein	NULL
identical	NULL
to	NULL
the	NULL
C-terminal	NULL
half	NULL
of	NULL
p110NF-xB	NULL
:	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
IxB	NULL
family	NULL
.	NULL

Cell	NULL
68:1109-1120	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
R.	NULL
Schmidt-Ullrich	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
1993	NULL
.	NULL

Promoter	NULL
analysis	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
IxBa/MAD-3	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
positive	NULL
regulation	NULL
by	NULL
members	NULL
of	NULL
the	NULL
rel/NF-	NULL
«	NULL
B	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:5043-5049	NULL
.	NULL

Liou	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
S.	NULL
Gosh	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
NF-kappa	NULL
B	NULL
p50	NULL
precursor	NULL
,	NULL
p105	NULL
contains	NULL
an	NULL
internal	NULL
I	NULL
kappa	NULL
B-like	NULL
inhibitor	NULL
that	NULL
preferentially	NULL
inhibits	NULL
p50	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:3003-3009	NULL
.	NULL

Liu	NULL
,	NULL
J.	NULL
,	NULL
N.	NULL
D.	NULL
Perkins	NULL
,	NULL
R.	NULL
M.	NULL
Schmid	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1992	NULL
.	NULL

Specific	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
act	NULL
in	NULL
concert	NULL
with	NULL
Tat	NULL
to	NULL
stimulate	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
transcription	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:3883-3887	NULL
.	NULL

Luznik	NULL
,	NULL
L.	NULL
,	NULL
G.	NULL
Kraus	NULL
,	NULL
J.	NULL
Guatelli	NULL
,	NULL
D.	NULL
Richman	NULL
,	NULL
and	NULL
F.	NULL
Wong-Staal	NULL
.	NULL

1995	NULL
.	NULL

Tat-independent	NULL
replication	NULL
of	NULL
human	NULL
immunodeficiency	NULL
viruses	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

95:328-332	NULL
.	NULL

McElhinny	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
S.	NULL
MacMorran	NULL
,	NULL
G.	NULL
D.	NULL
Bren	NULL
,	NULL
R.	NULL
M.	NULL
Ten	NULL
,	NULL
A.	NULL
Israél	NULL
,	NULL
and	NULL
C.	NULL
V.	NULL
Paya	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
IxBa	NULL
and	NULL
p105	NULL
in	NULL
monocytes	NULL
and	NULL
macrophages	NULL
persistently	NULL
infected	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:1500-1509	NULL
.	NULL

Mechti	NULL
,	NULL
N.	NULL
,	NULL
M.	NULL
Piechaczyck	NULL
,	NULL
J.M	NULL
.	NULL

Blanchard	NULL
,	NULL
L.	NULL
Marty	NULL
,	NULL
A.	NULL
Bonnieu	NULL
,	NULL
P.	NULL
Jeanteur	NULL
,	NULL
and	NULL
B.	NULL
Lebleu	NULL
.	NULL

1986	NULL
.	NULL

Transcriptional	NULL
and	NULL
post-transcriptional	NULL
regulation	NULL
of	NULL
c-myc	NULL
expression	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
murine	NULL
erythroleu-kemia	NULL
Friend	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14:9653-9666	NULL
.	NULL

Mellits	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
R.	NULL
T.	NULL
Hay	NULL
,	NULL
and	NULL
S.	NULL
Goodbourn	NULL
.	NULL

1993	NULL
.	NULL

Proteolitic	NULL
degradation	NULL
of	NULL
MAD-3	NULL
(	NULL
IxBa	NULL
)	NULL
and	NULL
enhanced	NULL
processing	NULL
of	NULL
the	NULL
NF-xB	NULL
precursor	NULL
p105	NULL
are	NULL
obligatory	NULL
steps	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:5059-5066	NULL
.	NULL

Meltzer	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
and	NULL
H.	NULL
E.	NULL
Gendelman	NULL
.	NULL

1992	NULL
.	NULL

Mononuclear	NULL
phagocytes	NULL
as	NULL
targets	NULL
,	NULL
tissue	NULL
reservoirs	NULL
,	NULL
and	NULL
immunoregulatory	NULL
cells	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
disease	NULL
,	NULL
p.	NULL
239-263	NULL
In	NULL
S.	NULL
W.	NULL
Russell	NULL
and	NULL
S.	NULL
Gordon	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Macrophages	NULL
biology	NULL
and	NULL
activation	NULL
.	NULL

Springer-Verlag	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Molinari	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
J.	NULL
Milner	NULL
.	NULL

1995.	NULL
p53	NULL
in	NULL
complex	NULL
with	NULL
DNA	NULL
is	NULL
resistant	NULL
to	NULL
ubiquitin-dependent	NULL
proteolysis	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HPV-16	NULL
F6	NULL
.	NULL

Oncogene	NULL
10:1849-1854	NULL
.	NULL

Moses	NULL
,	NULL
A.	NULL
V.	NULL
,	NULL
C.	NULL
Ibanez	NULL
,	NULL
R.	NULL
Gaynor	NULL
,	NULL
P.	NULL
Ghazal	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Nelson	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
role	NULL
of	NULL
long	NULL
terminal	NULL
repeat	NULL
control	NULL
elements	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
basal	NULL
and	NULL
Tat-mediated	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
primary	NULL
human	NULL
macrophages	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:298-307	NULL
.	NULL

Mounts	NULL
,	NULL
P.	NULL
,	NULL
T.-C.	NULL
Wu	NULL
,	NULL
and	NULL
K.	NULL
Peden	NULL
.	NULL

1989	NULL
.	NULL

Method	NULL
for	NULL
cloning	NULL
single-stranded	NULL
oligonucleotides	NULL
in	NULL
plasmid	NULL
vector	NULL
.	NULL

BioTechniques	NULL
7:356-359	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
that	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:711-713	NULL
.	NULL

Palombella	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
O.	NULL
Rando	NULL
,	NULL
A.	NULL
L.	NULL
Goldberg	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
ubiquitin-proteasome	NULL
pathway	NULL
is	NULL
required	NULL
for	NULL
processing	NULL
the	NULL
NF-	NULL
«	NULL
B1	NULL
precursor	NULL
protein	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Cell	NULL
78:773-785	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

Paya	NULL
,	NULL
C.	NULL
,	NULL
R.	NULL
Ten	NULL
,	NULL
C.	NULL
Bessia	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
R.	NULL
T.	NULL
Hay	NULL
,	NULL
and	NULL
J.-L.	NULL
Virelizier	NULL
.	NULL

1992	NULL
.	NULL

NF-	NULL
«	NULL
B-dependent	NULL
induction	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
subunit	NULL
gene	NULL
promoter	NULL
underlies	NULL
self-perpetuation	NULL
of	NULL
HIV	NULL
transcription	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7826-7830	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Agranoff	NULL
,	NULL
E.	NULL
Pascal	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
interaction	NULL
between	NULL
the	NULL
DNA-binding	NULL
domains	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
and	NULL
Sp1	NULL
mediates	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
gene	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6570-6583	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
N.	NULL
Lawrence	NULL
Edwards	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Agranoff	NULL
,	NULL
R.	NULL
M.	NULL
Schmid	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
cooperative	NULL
interaction	NULL
between	NULL
NF-kB	NULL
and	NULL
Sp1	NULL
is	NULL
required	NULL
for	NULL
HIV-1	NULL
enhancer	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:3551-3558	NULL
.	NULL

Poli	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
L.	NULL
Kinter	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1994	NULL
.	NULL

Interleukin	NULL
1	NULL
induced	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
alone	NULL
and	NULL
in	NULL
synergy	NULL
with	NULL
interleukin	NULL
6	NULL
in	NULL
chronically	NULL
infected	NULL
U1	NULL
cells	NULL
:	NULL
inhibition	NULL
of	NULL
inductive	NULL
effects	NULL
by	NULL
the	NULL
interleukin	NULL
1	NULL
receptor	NULL
antagonist	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:108-112	NULL
.	NULL

Poli	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Kinter	NULL
,	NULL
J.	NULL
S.	NULL
Justement	NULL
,	NULL
J.	NULL
H.	NULL
Kehrl	NULL
,	NULL
P.	NULL
Bressler	NULL
,	NULL
S.	NULL
Stanley	NULL
,	NULL
and	NULL
A.	NULL
Fauci	NULL
.	NULL

1990	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
functions	NULL
in	NULL
an	NULL
autocrine	NULL
manner	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:782-785	NULL
.	NULL

Pomerantz	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
D.	NULL
Trono	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Cells	NULL
nonproductively	NULL
infected	NULL
with	NULL
HIV-1	NULL
exhibit	NULL
an	NULL
aberrant	NULL
pattern	NULL
of	NULL
viral	NULL
RNA	NULL
expression	NULL
:	NULL
a	NULL
molecular	NULL
model	NULL
for	NULL
latency	NULL
.	NULL

Cell	NULL
61:1271-1276	NULL
.	NULL

Ponte	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
Y.	NULL
Ng	NULL
,	NULL
J.	NULL
Engel	NULL
,	NULL
P.	NULL
Gunning	NULL
,	NULL
and	NULL
L.	NULL
Kedes	NULL
.	NULL

1984	NULL
.	NULL

Evolutionary	NULL
conservation	NULL
in	NULL
the	NULL
untranslated	NULL
regions	NULL
of	NULL
actin	NULL
mRNAs	NULL
:	NULL
DNA	NULL
sequence	NULL
of	NULL
human	NULL
beta-actin	NULL
cDNA	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

12:1687-1696	NULL
.	NULL

Rock	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
C.	NULL
Gramm	NULL
,	NULL
L.	NULL
Rothstein	NULL
,	NULL
K.	NULL
Clark	NULL
,	NULL
R.	NULL
Stein	NULL
,	NULL
L.	NULL
Dick	NULL
,	NULL
D.	NULL
Hwang	NULL
,	NULL
and	NULL
A.	NULL
L.	NULL
Goldberg	NULL
.	NULL

1994	NULL
.	NULL

Inhibitors	NULL
of	NULL
the	NULL
proteasome	NULL
block	NULL
degradation	NULL
of	NULL
most	NULL
cell	NULL
proteins	NULL
and	NULL
the	NULL
generation	NULL
of	NULL
peptides	NULL
presented	NULL
on	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
.	NULL

Cell	NULL
78:761-771	NULL
.	NULL

Roff	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Thompson	NULL
,	NULL
L.	NULL
Rothstein	NULL
,	NULL
M.	NULL
S.	NULL
Rodriguez	NULL
,	NULL
J.M	NULL
.	NULL

Jacqué	NULL
,	NULL
F.	NULL
Baleux	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
and	NULL
R.	NULL
T.	NULL
Hay	NULL
.	NULL

Role	NULL
of	NULL
IxB	NULL
«	NULL
ubiquitination	NULL
signal	NULL
induced	NULL
activation	NULL
of	NULL
NF-kB	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
in	NULL
press	NULL
.	NULL

Roulston	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Beauparlant	NULL
,	NULL
N.	NULL
Rice	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1993	NULL
.	NULL

Chronic	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
stimulates	NULL
distinct	NULL
NF-	NULL
«	NULL
B/rel	NULL
DNA	NULL
binding	NULL
activities	NULL
in	NULL
myelomonoblastic	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:5235-5246	NULL
.	NULL

Roulston	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
Lin	NULL
,	NULL
P.	NULL
Beauparlant	NULL
,	NULL
M.	NULL
A.	NULL
Wainberg	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
and	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
myeloid	NULL
cells	NULL
by	NULL
NF-xB/Rel	NULL
transcription	NULL
factors	NULL
.	NULL

Microbiol	NULL
.	NULL

Rev	NULL
.	NULL

59:481-505	NULL
.	NULL

Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
strong	NULL
transcription	NULL
activating	NULL
potential	NULL
of	NULL
NF-kB	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:3805-3817	NULL
.	NULL

Schwartz	NULL
,	NULL
O.	NULL
,	NULL
J.-L.	NULL
Virelizier	NULL
,	NULL
L.	NULL
Montagnier	NULL
,	NULL
and	NULL
U.	NULL
Hazan	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
micro-transfection	NULL
method	NULL
using	NULL
luciferase	NULL
gene	NULL
for	NULL
the	NULL
study	NULL
of	NULL
HIV	NULL
LTR	NULL
activity	NULL
.	NULL

Gene	NULL
88:197-205	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
P.	NULL
A.	NULL
Ganchi	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1993	NULL
.	NULL

NF-kB	NULL
controls	NULL
expression	NULL
of	NULL
inhibitor	NULL
IxB-	NULL
«	NULL
:	NULL
evidence	NULL
for	NULL
an	NULL
inducible	NULL
autoregu-latory	NULL
pathway	NULL
.	NULL

Science	NULL
259:1912-1915	NULL
.	NULL

Taylor	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
R.	NULL
Pomerantz	NULL
,	NULL
O.	NULL
Bagasra	NULL
,	NULL
M.	NULL
Chowdhury	NULL
,	NULL
J.	NULL
Rappaport	NULL
,	NULL
K.	NULL
Khalili	NULL
,	NULL
and	NULL
S.	NULL
Amini	NULL
.	NULL

1992	NULL
.	NULL

TAR-independent	NULL
transactivation	NULL
by	NULL
Tat	NULL
in	NULL
cells	NULL
derived	NULL
from	NULL
the	NULL
CNS	NULL
:	NULL
a	NULL
novel	NULL
mechanism	NULL
of	NULL
HIV-1	NULL
gene	NULL
regulation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:3395-3403	NULL
.	NULL

Thompson	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
R.	NULL
J.	NULL
Phillips	NULL
,	NULL
H.	NULL
Erdjument-Bromage	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

1995	NULL
.	NULL

IxB-8	NULL
regulates	NULL
the	NULL
persistent	NULL
response	NULL
in	NULL
a	NULL
biphasic	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Cell	NULL
80:573-582	NULL
.	NULL

Traencker	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
S.	NULL
Wilk	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
proteasome	NULL
inhibitor	NULL
prevents	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
stabilizes	NULL
a	NULL
newly	NULL
phosphorylated	NULL
form	NULL
of	NULL
IxB-	NULL
«	NULL
that	NULL
is	NULL
still	NULL
bound	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:5433-5441	NULL
.	NULL

Vliach	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
Garcia	NULL
,	NULL
J.-M.	NULL
Jacqué	NULL
,	NULL
M.	NULL
S.	NULL
Rodriguez	NULL
,	NULL
S.	NULL
Michelson	NULL
,	NULL
and	NULL
J.-L.	NULL
Virelizier	NULL
.	NULL

1995	NULL
.	NULL

Induction	NULL
of	NULL
Sp1	NULL
phosphorylation	NULL
and	NULL
NF-	NULL
«	NULL
B-independent	NULL
HIV	NULL
promoter	NULL
domain	NULL
activity	NULL
in	NULL
T	NULL
lymphocytes	NULL
stimulated	NULL
by	NULL
okadaic	NULL
acid	NULL
.	NULL

Virology	NULL
208:753-761	NULL
.	NULL

Wei	NULL
,	NULL
X.	NULL
,	NULL
S.	NULL
K.	NULL
Ghosh	NULL
,	NULL
M.	NULL
E.	NULL
Taylor	NULL
,	NULL
V.	NULL
A.	NULL
Johnson	NULL
,	NULL
E.	NULL
A.	NULL
Emini	NULL
,	NULL
P.	NULL
Deutsch	NULL
,	NULL
J.	NULL
D.	NULL
Lifson	NULL
,	NULL
S.	NULL
Bonhoeffer	NULL
,	NULL
M.	NULL
A.	NULL
Nowak	NULL
,	NULL
B.	NULL
H.	NULL
Hahn	NULL
,	NULL
M.	NULL
S.	NULL
Saag	NULL
,	NULL
and	NULL
G.	NULL
M.	NULL
Chaw	NULL
.	NULL

1995	NULL
.	NULL

Viral	NULL
dynamics	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
373:117-122	NULL
.	NULL

Wulezyn	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
M.	NULL
Naumann	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1992	NULL
.	NULL

Candidate	NULL
proto-oncogene	NULL
bel-3	NULL
encodes	NULL
a	NULL
subunit-specific	NULL
inhibitor	NULL
of	NULL
transcription	NULL
factor	NULL
NF-kappa	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
358:597-599	NULL
.	NULL

Zack	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
Arrigo	NULL
,	NULL
S.	NULL
R.	NULL
Weitsman	NULL
,	NULL
A	NULL
.	NULL

Go	NULL
,	NULL
A.	NULL
Haislip	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
.	NULL

1990	NULL
.	NULL

HIV-1	NULL
entry	NULL
into	NULL
quiescent	NULL
primary	NULL
lymphocytes	NULL
:	NULL
molecular	NULL
analysis	NULL
reveals	NULL
a	NULL
labile	NULL
,	NULL
latent	NULL
viral	NULL
structure	NULL
.	NULL

Cell	NULL
61:213-222	NULL
.	NULL

